<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Front Mol Biosci</journal-id>
    <journal-id journal-id-type="iso-abbrev">Front Mol Biosci</journal-id>
    <journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
    <journal-title-group>
      <journal-title>Frontiers in Molecular Biosciences</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2296-889X</issn>
    <publisher>
      <publisher-name>Frontiers Media S.A.</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4914951</article-id>
    <article-id pub-id-type="doi">10.3389/fmolb.2016.00026</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Molecular Biosciences</subject>
        <subj-group>
          <subject>Original Research</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title><italic>biosigner</italic>: A New Method for the Discovery of Significant Molecular Signatures from Omics Data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Rinaudo</surname>
          <given-names>Philippe</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/348452/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Boudah</surname>
          <given-names>Samia</given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
          <sup>2</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/339647/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Junot</surname>
          <given-names>Christophe</given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Thévenot</surname>
          <given-names>Etienne A.</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <xref ref-type="author-notes" rid="fn001">
          <sup>*</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/302382/overview"/>
      </contrib>
    </contrib-group>
    <aff id="aff1">
      <sup>1</sup>
      <institution>CEA, LIST, Laboratory for Data Analysis and Systems' Intelligence, MetaboHUB</institution>
      <country>Gif-sur-Yvette, France</country>
    </aff>
    <aff id="aff2">
      <sup>2</sup>
      <institution>Laboratoire d'Etude du Métabolisme des Médicaments, DSV/iBiTec-S/SPI, MetaboHUB, CEA-Saclay</institution>
      <country>Gif-sur-Yvette, France</country>
    </aff>
    <author-notes>
      <fn fn-type="edited-by">
        <p>Edited by: Wolfram Weckwerth, University of Vienna, Austria</p>
      </fn>
      <fn fn-type="edited-by">
        <p>Reviewed by: Tomohisa Hasunuma, Kobe University, Japan; Michal Jan Markuszewski, Medical University of Gdansk, Poland</p>
      </fn>
      <corresp id="fn001">*Correspondence: Etienne A. Thévenot <email xlink:type="simple">etienne.thevenot@cea.fr</email></corresp>
      <fn fn-type="other" id="fn002">
        <p>This article was submitted to Metabolomics, a section of the journal Frontiers in Molecular Biosciences</p>
      </fn>
    </author-notes>
    <pub-date pub-type="epub">
      <day>21</day>
      <month>6</month>
      <year>2016</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2016</year>
    </pub-date>
    <volume>3</volume>
    <elocation-id>26</elocation-id>
    <history>
      <date date-type="received">
        <day>21</day>
        <month>12</month>
        <year>2016</year>
      </date>
      <date date-type="accepted">
        <day>03</day>
        <month>6</month>
        <year>2016</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2016 Rinaudo, Boudah, Junot and Thévenot.</copyright-statement>
      <copyright-year>2016</copyright-year>
      <copyright-holder>Rinaudo, Boudah, Junot and Thévenot</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
      </license>
    </permissions>
    <abstract>
      <p>High-throughput technologies such as transcriptomics, proteomics, and metabolomics show great promise for the discovery of biomarkers for diagnosis and prognosis. Selection of the most promising candidates between the initial untargeted step and the subsequent validation phases is critical within the pipeline leading to clinical tests. Several statistical and data mining methods have been described for feature selection: in particular, wrapper approaches iteratively assess the performance of the classifier on distinct subsets of variables. Current wrappers, however, do not estimate the significance of the selected features. We therefore developed a new methodology to find the smallest feature subset which significantly contributes to the model performance, by using a combination of resampling, ranking of variable importance, significance assessment by permutation of the feature values in the test subsets, and half-interval search. We wrapped our <italic>biosigner</italic> algorithm around three reference binary classifiers (Partial Least Squares—Discriminant Analysis, Random Forest, and Support Vector Machines) which have been shown to achieve specific performances depending on the structure of the dataset. By using three real biological and clinical metabolomics and transcriptomics datasets (containing up to 7000 features), complementary signatures were obtained in a few minutes, generally providing higher prediction accuracies than the initial full model. Comparison with alternative feature selection approaches further indicated that our method provides signatures of restricted size and high stability. Finally, by using our methodology to seek metabolites discriminating type 1 from type 2 diabetic patients, several features were selected, including a fragment from the taurochenodeoxycholic bile acid. Our methodology, implemented in the <italic>biosigner</italic> R/Bioconductor package and Galaxy/Workflow4metabolomics module, should be of interest for both experimenters and statisticians to identify robust molecular signatures from large omics datasets in the process of developing new diagnostics.</p>
    </abstract>
    <kwd-group>
      <kwd>feature selection</kwd>
      <kwd>biomarker</kwd>
      <kwd>molecular signature</kwd>
      <kwd>omics data</kwd>
      <kwd>partial least squares</kwd>
      <kwd>support vector machine</kwd>
      <kwd>random forest</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source id="cn001">Agence Nationale de la Recherche<named-content content-type="fundref-id">10.13039/501100001665</named-content></funding-source>
        <award-id rid="cn001">ANR-11-INBS-0010</award-id>
      </award-group>
      <award-group>
        <funding-source id="cn002">Seventh Framework Programme<named-content content-type="fundref-id">10.13039/501100004963</named-content></funding-source>
        <award-id rid="cn002">305499</award-id>
      </award-group>
    </funding-group>
    <counts>
      <fig-count count="5"/>
      <table-count count="2"/>
      <equation-count count="1"/>
      <ref-count count="69"/>
      <page-count count="14"/>
      <word-count count="10000"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="s1">
    <title>1. Introduction</title>
    <p>High-throughput, non-targeted, technologies such as transcriptomics, proteomics, and metabolomics, show great promise for the discovery of molecular markers which allow to efficiently discriminate between biological or clinical conditions of interest (e.g., disease vs. control states; Nicholson, <xref rid="B44" ref-type="bibr">2006</xref>; van 't Veer and Bernards, <xref rid="B63" ref-type="bibr">2008</xref>; Boja et al., <xref rid="B6" ref-type="bibr">2011</xref>). In particular, metabolomics, by focusing on the end-product of biochemical reactions, has a strong potential for phenotype characterization and biomarker discovery (Holmes et al., <xref rid="B32" ref-type="bibr">2008</xref>; Zhang et al., <xref rid="B67" ref-type="bibr">2015</xref>). Recent studies have described candidate biomarkers for the diagnosis or prognosis of many diseases, including diabetes (Wang et al., <xref rid="B64" ref-type="bibr">2011</xref>), kidney diseases (Rowe et al., <xref rid="B51" ref-type="bibr">2013</xref>; Zhao, <xref rid="B68" ref-type="bibr">2013</xref>; Posada-Ayala et al., <xref rid="B45" ref-type="bibr">2014</xref>), cancer (Chen et al., <xref rid="B11" ref-type="bibr">2011</xref>; Armitage and Barbas, <xref rid="B2" ref-type="bibr">2014</xref>), and neurodegenerative diseases (Graham et al., <xref rid="B26" ref-type="bibr">2013</xref>; Mapstone et al., <xref rid="B40" ref-type="bibr">2014</xref>).</p>
    <p>Powerful statistical and data mining approaches have been developed to learn classification rules from omics datasets despite the high feature over sample ratio and the large proportion of correlated features (Trygg et al., <xref rid="B62" ref-type="bibr">2007</xref>; Scott et al., <xref rid="B53" ref-type="bibr">2013</xref>; Tarca et al., <xref rid="B57" ref-type="bibr">2013</xref>). Such approaches include Support Vector Machines (SVM; Boser et al., <xref rid="B7" ref-type="bibr">1992</xref>), Partial Least Square—Discriminant Analysis (PLS-DA; Wold et al., <xref rid="B66" ref-type="bibr">2001</xref>; Barker and Rayens, <xref rid="B4" ref-type="bibr">2003</xref>), and Random Forest (Breiman, <xref rid="B8" ref-type="bibr">2001</xref>), which have been widely used in transcriptomics, proteomics, and metabolomics (Brown et al., <xref rid="B9" ref-type="bibr">2000</xref>; Diaz-Uriarte and Alvarez de Andres, <xref rid="B16" ref-type="bibr">2006</xref>; Madsen et al., <xref rid="B39" ref-type="bibr">2010</xref>; Robotti et al., <xref rid="B49" ref-type="bibr">2014</xref>). Although these models can achieve good predictions accuracies, the excess of features in the training dataset increases both the risk of overfitting and the prediction variability. In addition, in the context of biomarker discovery and clinical diagnostic, selection of a restricted list of candidate markers is mandatory before entering the subsequent qualification/verification phases (Baker, <xref rid="B3" ref-type="bibr">2005</xref>; Rifai et al., <xref rid="B47" ref-type="bibr">2006</xref>; Keating and Cambrosio, <xref rid="B33" ref-type="bibr">2012</xref>).</p>
    <p>Since the comprehensive analysis of all 2<sup><italic>p</italic></sup> combinations of <italic>p</italic> features is not computationally tractable for large omics datasets, several statistical and data mining techniques for feature selection have been described with the common goal of extracting a restricted list of variables (i.e., a molecular signature) still providing high performance of the classifier (Guyon and Elisseeff, <xref rid="B28" ref-type="bibr">2003</xref>; Saeys et al., <xref rid="B52" ref-type="bibr">2007</xref>). One strategy consists in filtering the features before building the classifier (Golub et al., <xref rid="B25" ref-type="bibr">1999</xref>). In such <italic>filter</italic> techniques, features are ranked according to a univariate (e.g., <italic>p</italic>-value from hypothesis testing of median differences between the two classes) or a multivariate metric (e.g., Variable Importance in Projection, VIP, from PLS-DA), and a threshold is applied. Filter methods are fast; however, since the selection is performed before the final model is built, the selected features may not be optimal for the classifier performance. In addition, the choice of the threshold may be subjective, and the size of the signature may be large. A second type of methods combines feature selection and model construction in a single step: by including a penalization constraint within the algorithm building the classifier, the <italic>embedded</italic> approaches limit the number of features with non-zero coefficients in the final model (e.g., Lasso, Tibshirani, <xref rid="B60" ref-type="bibr">1996</xref>, Elastic Net, Zou and Hastie, <xref rid="B69" ref-type="bibr">2005</xref>, and sparse PLS, Chun and Keles, <xref rid="B13" ref-type="bibr">2010</xref>). Such strategies are computationally efficient but the signature may be large and subject to substantial variation upon repetition of the algorithm (instability). Moreover, only one type of classifier is used, whereas several studies have shown that best classification performances are obtained by distinct models depending on the structure of the dataset (Guo et al., <xref rid="B27" ref-type="bibr">2010</xref>; Tarca et al., <xref rid="B57" ref-type="bibr">2013</xref>; Determan, <xref rid="B15" ref-type="bibr">2015</xref>). Therefore, a third category of approaches, called <italic>wrapper</italic> methods, are of interest because they can be applied to any classifier, and take into account the specificities of the classifier in the process of feature selection (Kohavi and John, <xref rid="B34" ref-type="bibr">1997</xref>).</p>
    <p>The <italic>wrapper</italic> feature selection methods (e.g., Recursive Feature Elimination, RFE, applied to SVM; Guyon et al., <xref rid="B29" ref-type="bibr">2002</xref>) iteratively (i) select groups of features which still provide a good classification accuracy, and (ii) re-build the model on the data subset. Several heuristics have been described to find optimal combination of features (either <italic>deterministic</italic>, such as forward and backward selection of individual or groups of variables, or <italic>stochastic</italic>, such as genetic algorithms or simulated annealing; Kuhn and Johnson, <xref rid="B36" ref-type="bibr">2013</xref>). A limitation of current wrapper methods is that the selection criterion is based on the classifier performance only: the added-value of including a particular group of features instead of noise into the model (which we call the feature subset <italic>significance</italic> hereafter) is not evaluated. Here, we therefore propose a new wrapper algorithm based on random permutation of feature intensities in test subsets obtained by resampling, to assess the significance of the features on the model performance. We wrapped our algorithm around three classifiers, namely PLS-DA, Random Forest, and SVM, and applied our feature selection approach to four real metabolomics and transcriptomics datasets, including one unpublished clinical LC-HRMS analysis of plasma samples from diabetic patients. We show that restricted, complementary, and stable molecular signatures are obtained, and that the corresponding models have high prediction accuracies.</p>
  </sec>
  <sec id="s2">
    <title>2. Theory</title>
    <p>The objective of our method is to find the significant feature subset necessary for a classifier to optimally discriminate between two classes. Given a machine learning methodology, our algorithm thus provides both the molecular signature (i.e., the significant feature subset) and the trained classifier, which can subsequently be used for prediction on new datasets. Feature selection is based on a backward procedure in which significance of each feature subset is estimated by random permutation of the intensities. The dataset is then restricted to the significant feature subset, and the whole procedure is performed iteratively until, for a given round, all candidate features are found significant (in this case the signature consists of these features), or until there is no feature left to be tested (in this case the signature is empty). The algorithm thus consists of three steps (Algorithm <xref ref-type="table" rid="T3">1</xref> and Figure <xref ref-type="fig" rid="F1">1</xref>):
<list list-type="order"><list-item><p><bold>Bootstrap resampling</bold>. A <italic>boot</italic> number of subsets (default is 50) are obtained by bootstrapping. Each subset consists of a training set (<italic>train</italic><sub><italic>k</italic>, 1 ≤ <italic>k</italic> ≤ <italic>boot</italic></sub>) and the inferred test set (<italic>test</italic><sub><italic>k</italic></sub>). On each <italic>train</italic><sub><italic>k</italic></sub> set, a model (<italic>model</italic><sub><italic>k</italic></sub>) is then trained. Note that no other model needs to be built up to step 4, thus reducing the computation burden. Each <italic>model</italic><sub><italic>k</italic></sub> is evaluated on the <italic>test</italic><sub><italic>k</italic></sub>, and the balanced prediction accuracy is computed (<italic>accuracy</italic><sub><italic>k</italic></sub>).</p></list-item><list-item><p><bold>Feature ranking</bold>. For each <italic>model</italic><sub><italic>k</italic></sub>, the features are ranked according to a metric <italic>rank</italic><sub><italic>k</italic></sub> (the default metric is variable importance in projection, VIP, for PLS-DA, Wold et al., <xref rid="B66" ref-type="bibr">2001</xref>, variable importance for Random Forest, Breiman, <xref rid="B8" ref-type="bibr">2001</xref>, and squared weights for SVM, Guyon et al., <xref rid="B29" ref-type="bibr">2002</xref>). Finally, the <italic>rank</italic><sub><italic>k</italic></sub> are aggregated by computing the median to obtain the final ranking:</p><p><disp-formula id="E1"><label>(1)</label><mml:math id="M1"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mi>R</mml:mi><mml:mi>A</mml:mi><mml:mi>N</mml:mi><mml:mi>K</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>M</mml:mi><mml:mi>E</mml:mi><mml:mi>D</mml:mi><mml:mi>I</mml:mi><mml:mi>A</mml:mi><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mi>k</mml:mi><mml:mo>≤</mml:mo><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p><p>where <italic>RANK</italic> and <italic>MEDIAN</italic> are the usual ranking and median functions.</p></list-item><list-item><p><bold>Selection of significant features</bold>. The objective of this step is to discard all non-significant features from the dataset. The method consists in finding the largest non-significant feature subset <italic>S</italic><sub><italic>f</italic></sub> = {<italic>g</italic>|<italic>rank</italic>(<italic>g</italic>) ≥ <italic>rank</italic>(<italic>f</italic>)} (or, equivalently, the feature <italic>f</italic><sub><italic>ns</italic></sub> of lowest rank such that <italic>S</italic><sub><italic>f</italic><sub><italic>ns</italic></sub></sub> is not significant). A half-interval search algorithm is used to find <italic>f</italic><sub><italic>ns</italic></sub>: for a given <italic>f</italic>, the significance of <italic>S</italic><sub><italic>f</italic></sub> is estimated by randomly permuting all <italic>S</italic><sub><italic>f</italic></sub> feature intensities in the <italic>test</italic><sub><italic>k</italic></sub> subsets (Figure <xref ref-type="fig" rid="F2">2</xref>), and computing the predictions accuracies of the <italic>model</italic><sub><italic>k</italic></sub> on these permuted subsets (<italic>accuracy</italic><sub><italic>k, perm</italic></sub>). If the proportion of <italic>accuracy</italic><sub><italic>k, perm</italic></sub> ≥ <italic>accuracy</italic><sub><italic>k</italic></sub> over all <italic>boot</italic> comparisons is above a defined threshold (5% by default), <italic>S</italic><sub><italic>f</italic></sub> is declared not significant, and the next candidate feature <italic>f</italic>′ has the rank closest to the mean of <italic>rank</italic>(<italic>h</italic>) − 1 and <italic>rank</italic>(<italic>f</italic>) + 1, where <italic>h</italic> is the last significant feature detected. Otherwise <italic>S</italic><sub><italic>f</italic></sub> is significant, and the next <italic>f</italic>′ is the feature with the rank closest to the mean of <italic>rank</italic>(<italic>f</italic>) − 1 and <italic>rank</italic>(<italic>l</italic>) + 1 where <italic>l</italic> is the last non-significant feature detected. At the end of the half-interval search, the dataset is restricted to the features of ranks &lt; <italic>rank</italic>(<italic>f</italic><sub><italic>ns</italic></sub>). If no feature has been found significant, the dataset is restricted to the half of features with lowest ranks, but these features are not registered as significant in this round.</p></list-item><list-item><p><bold>Building the final model</bold>. Steps 1–3 are repeated until, for a given round, candidate features are all found significant (these features then correspond to the signature), or until there is no feature left to be tested (the signature is empty). When the signature is not empty, the final model is then obtained by a single training on the dataset containing all observations and restricted to the features from the signature.</p></list-item></list></p>
    <table-wrap id="T3" position="float">
      <label>Algorithm 1</label>
      <caption>
        <p>The <italic>biosigner</italic> algorithm. The inputs are <bold>X</bold>: <italic>sample</italic> × <italic>feature</italic> matrix of intensities; α: significance level; and <italic>boot</italic>: number of bootstraps.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <tbody>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> 1:  <bold>function</bold> <monospace>BIOSIGNER</monospace>(<bold>X</bold>, α, <italic>boot</italic>)</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> 2:       <bold>while</bold> the algorithm has not converged and <bold>X</bold> contains features <bold>do</bold></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> 3:            Create <italic>boot</italic> training sets <italic>train</italic><sub><italic>k</italic></sub> and test sets <italic>test</italic><sub><italic>k</italic></sub> by bootstrapping [step 1]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> 4:            <bold>for</bold> each training set <italic>train</italic><sub><italic>k</italic></sub> <bold>do</bold></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> 5:               Train the model <italic>model</italic><sub><italic>k</italic></sub></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> 6:               Compute the feature ranking <italic>rank</italic><sub><italic>k</italic></sub> according to the selected metric</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> 7:               Compute the balanced prediction accuracy <italic>accuracy</italic><sub><italic>k</italic></sub> using <italic>test</italic><sub><italic>k</italic></sub></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> 8:            <bold>end for</bold></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> 9:            Compute the feature final ranking according to equation 1 [step 2]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">10:           Half-interval search for the largest non-significant feature subset <italic>S</italic> using α as the threshold rate [step 3]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">11:           Restrict <bold>X</bold> to the features not in <italic>S</italic></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">12:       <bold>end while</bold></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">13:       Repeat the <bold>while</bold> procedure above until either <bold>X</bold> is constant (i.e., the <italic>S</italic> subset from the last round was empty), or until<break/>           <bold>X</bold> does not contain any feature left [step 4]</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">14:       If <bold>X</bold> contains features, return the model trained on <bold>X</bold></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">15:  <bold>end function</bold></td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p><bold>Description of the <italic>biosigner</italic> algorithm for feature selection (see Section 2 for details)</bold>. The algorithm is wrapped around the PLS-DA, Random Forest, and SVM binary classifiers.</p>
      </caption>
      <graphic xlink:href="fmolb-03-00026-g0001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p><bold>Determination of the largest non-significant subset of features (step 3 of the <italic>biosigner</italic> algorithm)</bold>. During the two first steps of the algorithm, the dataset has been split into train and test subsets by resampling, and features have been ranked according to their aggregated importance for the classifier built on the train subsets (the lower the rank, the higher the importance). In this third step, half-interval search is used to find the feature of lowest rank, <italic>f</italic><sub><italic>ns</italic></sub> such that the subset <italic>S</italic><sub><italic>f</italic><sub><italic>ns</italic></sub></sub> of all features with ranks ≥<italic>rank</italic>(<italic>f</italic><sub><italic>ns</italic></sub>) is not significant (i.e., random permutation of all <italic>S</italic><sub><italic>f</italic><sub><italic>ns</italic></sub></sub> feature intensities in the test subsets does not significantly decrease the prediction accuracy of the model). In this example, the permutation of all features (green, 1st iteration) significantly reduced model accuracy, but not the permutation of the 50% features with highest ranks (red, 2nd iteration), nor the 75% of features with highest ranks (red, 3rd iteration).</p>
      </caption>
      <graphic xlink:href="fmolb-03-00026-g0002"/>
    </fig>
  </sec>
  <sec id="s3">
    <title>3. Materials and methods</title>
    <sec>
      <title>3.1. Datasets</title>
      <list list-type="bullet">
        <list-item>
          <p>
            <bold>LC-HRMS metabolomics</bold>
            <list list-type="bullet">
              <list-item>
                <p><italic>sacurine</italic>: Urine from human adults</p>
                <p>The metabolomics analysis of urine samples from a cohort of employees from the CEA Saclay research institute by liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS) has been described previously (Roux et al., <xref rid="B50" ref-type="bibr">2012</xref>; Thevenot et al., <xref rid="B59" ref-type="bibr">2015</xref>). Briefly, the samples were analyzed by ultra-high performance liquid chromatography (Hypersil GOLD C18 column, Thermo Fisher) coupled to a high-resolution mass spectrometer (LTQ-Orbitrap Discovery, Thermo Fisher). The raw files were preprocessed by using the XCMS (Smith et al., <xref rid="B54" ref-type="bibr">2006</xref>) and the CAMERA R packages (Kuhl et al., <xref rid="B35" ref-type="bibr">2012</xref>). Annotation at levels 1 and 2 from the metabolomics standard initiative (MSI; Sumner et al., <xref rid="B55" ref-type="bibr">2007</xref>) was performed by in-house and public databases query in addition to MS/MS experiments. Finally, the intensities of the annotated metabolites were validated by using the Quan Browser module from the Xcalibur software (Thermo Fisher), corrected for signal drift and batch-effect, and <italic>log</italic><sub>10</sub> transformed (Thevenot et al., <xref rid="B59" ref-type="bibr">2015</xref>). Here, we used the <italic>sacurine</italic> subset corresponding to the negative ionization mode, which consists of 183 samples and 109 annotated metabolites, and is available from the <italic>ropls</italic> R Bioconductor package.</p>
              </list-item>
              <list-item>
                <p><italic>spikedApples</italic>: Apples spiked with known compounds</p>
                <p>One <italic>control</italic> group of 10 apples and several <italic>spiked</italic> sets of the same size have been analyzed by LC-HRMS (SYNAPT Q-TOF, Waters; Franceschi et al., <xref rid="B20" ref-type="bibr">2012</xref>). The spiked mixtures consisted of 2 compounds which were not naturally present in the matrix, and 7 compounds aimed at achieving a final increase of 20–100% of the endogeneous concentrations. The dataset is included in the <italic>BioMark</italic> R Bioconductor package (Franceschi et al., <xref rid="B20" ref-type="bibr">2012</xref>). The <italic>control</italic> and the first <italic>spiked</italic> groups (i.e., a total of 20 samples) were used in this study.</p>
              </list-item>
              <list-item>
                <p><italic>diaplasma</italic>: Plasma from diabetic patients</p>
                <p>Collection of plasma samples from type 1 and type 2 diabetic patients (Hôtel-Dieu, Paris, France) was performed with informed consent of the subjects, in accordance with the 1964 Helsinki declaration and its later amendments. Samples were analyzed by ultra-high performance liquid chromatography (Nexera, Shimadzu) coupled to a high resolution mass spectrometry operating in the negative ionization mode (Orbitrap Exactive, Thermo Fisher). Raw data were processed with XCMS (Smith et al., <xref rid="B54" ref-type="bibr">2006</xref>) and CAMERA (Kuhl et al., <xref rid="B35" ref-type="bibr">2012</xref>), and the resulting peak table was annotated by matching the measured m/z and retention times against an in-house database from MS spectra of pure compounds. Signal drift was corrected by using a loess fit of the intensities from quality control (<italic>pool</italic>) samples injected periodically (Dunn et al., <xref rid="B17" ref-type="bibr">2011</xref>; Thevenot et al., <xref rid="B59" ref-type="bibr">2015</xref>). Features which did not meet the following quality control criteria were discarded: (i) ratio of mean intensity in samples over mean intensity in blanks (mobile phase only) &gt;2, (ii) significant correlation between the intensities of the diluted pool samples and the dilution factor, and (iii) coefficient of variation of pool intensities &lt; 30%. Five samples with <italic>p</italic>-values &lt; 0.001 by using either the Hotellings' <italic>T</italic><sup>2</sup> outlier test, or the Z-score corresponding to the highest deviation of intensity quantiles (Alonso et al., <xref rid="B1" ref-type="bibr">2011</xref>) were removed. Finally, the intensities were <italic>log</italic><sub>10</sub> transformed and the few missing values (&lt; 0.01%) were set to 0.</p>
              </list-item>
            </list>
          </p>
        </list-item>
        <list-item>
          <p>
            <bold>Microarray transcriptomics</bold>
            <list list-type="bullet">
              <list-item>
                <p><italic>leukemia</italic>: Bone marrow from acute leukemia patients</p>
                <p>Samples from patients with acute lymphoblastic (ALL, 47 patients) or myeloid (AML, 25 patients) leukemia have been analyzed by using Aymetrix Hgu6800 chips. The resulting dataset contains expression data from 7129 gene probes (Golub et al., <xref rid="B25" ref-type="bibr">1999</xref>), and is available from the <italic>golubEsets</italic> R Bioconductor package.</p>
              </list-item>
            </list>
          </p>
        </list-item>
      </list>
    </sec>
    <sec>
      <title>3.2. The <italic>biosigner</italic> algorithm</title>
      <p>The principles of the algorithm are detailed in the <italic>Theory</italic> section and are illustrated in Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref>.</p>
      <sec>
        <title>3.2.1. Wrapped classifiers</title>
        <p>The algorithm was independently wrapped around three machine learning approaches, namely Partial Least Squares—Discriminant Analysis (PLS-DA), Random Forest, and Support Vector Machines (SVM), by using the following implementations:
<list list-type="bullet"><list-item><p><bold>Partial Least Squares Discriminant Analysis (PLS-DA)</bold></p><p>The PLS-DA implementation from the <italic>ropls</italic> bioconductor package (Thevenot et al., <xref rid="B59" ref-type="bibr">2015</xref>; version 1.2.2) was used after mean-centering and unit-variance scaling of the features. Briefly, the binary response is converted to a numeric vector <bold>y</bold> of values in {-0.5; 0.5}, and a PLS regression is performed with the NIPALS algorithm (Wold et al., <xref rid="B66" ref-type="bibr">2001</xref>; Barker and Rayens, <xref rid="B4" ref-type="bibr">2003</xref>). The number of components is determined automatically as follows (Eriksson et al., <xref rid="B18" ref-type="bibr">2001</xref>): a new component <italic>h</italic> is added to the model if :
<list list-type="order"><list-item><p><italic>R</italic>2<italic>Y</italic><sub><italic>h</italic></sub> ≥ 1%, i.e., the percentage of <bold>y</bold> variance explained by component <italic>h</italic> is more than 1%, and</p></list-item><list-item><p><italic>Q</italic>2<italic>Y</italic><sub><italic>h</italic></sub> = 1 − <italic>PRESS</italic><sub><italic>h</italic></sub> ∕ <italic>RSS</italic><sub><italic>h</italic>−1</sub> ≥ 0 (or 5% when the number of samples is less than 100), i.e., the predicted residual sum of squares (<italic>PRESS</italic><sub><italic>h</italic></sub>) of the model including the new component <italic>h</italic> estimated by 7-fold cross-validation is less than the residual sum of squares (<italic>RSS</italic><sub><italic>h</italic> − 1</sub>) of the model with the previous components only (with <italic>RSS</italic><sub>0</sub> = (<italic>n</italic> − 1)<italic>var</italic>(<bold>y</bold>)).</p></list-item></list></p></list-item></list></p>
        <p>Finally, the predictive performance of the full model is assessed by the cumulative <italic>Q</italic>2<italic>Y</italic> metric: <inline-formula><mml:math id="M2"><mml:mi>Q</mml:mi><mml:mn>2</mml:mn><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mstyle displaystyle="true"><mml:munderover accentunder="false" accent="false"><mml:mrow><mml:mo>∏</mml:mo></mml:mrow><mml:mrow><mml:mi>h</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>r</mml:mi></mml:mrow></mml:munderover></mml:mstyle><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>Q</mml:mi><mml:mn>2</mml:mn><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. We have <italic>Q</italic>2<italic>Y</italic> ∈ [0, 1], and the higher the <italic>Q</italic>2<italic>Y</italic>, the better the performance. However, models trained on datasets with a larger number of features compared with the number of samples can be prone to overfitting: in that case, high <italic>Q</italic>2<italic>Y</italic> values are obtained by chance only. To estimate the significance of <italic>Q</italic>2<italic>Y</italic> (and <italic>R</italic>2<italic>Y</italic>) values, Szymanska et al. (<xref rid="B56" ref-type="bibr">2012</xref>) therefore proposed to perform permutation testing: models are built after random permutation of the <bold>y</bold> values, and <italic>Q</italic>2<italic>Y</italic><sub><italic>perm</italic></sub> are computed. The <italic>p</italic>-value is equal to the proportion of <italic>Q</italic>2<italic>Y</italic><sub><italic>perm</italic></sub> above <italic>Q</italic>2<italic>Y</italic> (in this study, the number of random permutations was set to 1000).</p>
        <list list-type="bullet">
          <list-item>
            <p>
              <bold>Random Forest</bold>
            </p>
            <p>The implementation of the method from Breiman (<xref rid="B8" ref-type="bibr">2001</xref>) in the <italic>randomForest</italic> R package was used (Liaw and Wiener, <xref rid="B37" ref-type="bibr">2002</xref>; version 4.6.10). The number of trees was set to 500, and the number of candidates randomly sampled at each split was the squared root of the total number of features.</p>
          </list-item>
          <list-item>
            <p>
              <bold>Support Vector Machine (SVM)</bold>
            </p>
            <p>The <italic>e1071</italic> R package (Meyer et al., <xref rid="B43" ref-type="bibr">2014</xref>; version 1.6.4) implements the <italic>libsvm</italic> algorithm (Chang and Lin, <xref rid="B10" ref-type="bibr">2011</xref>). Features were mean-centered and unit-variance scaled prior to linear SVM modeling with <italic>cost</italic> = 1.</p>
          </list-item>
        </list>
      </sec>
      <sec>
        <title>3.2.2. Resampling (step 1)</title>
        <p>The default number of bootstraps was 50.</p>
      </sec>
      <sec>
        <title>3.2.3. Feature ranking (step 2)</title>
        <p>The following metrics were used: the variable importance in projection (VIP) for PLS-DA (Wold et al., <xref rid="B66" ref-type="bibr">2001</xref>), the variable importance based on the error rate for Random Forest (Breiman, <xref rid="B8" ref-type="bibr">2001</xref>), and the squared weights for SVM (Guyon et al., <xref rid="B29" ref-type="bibr">2002</xref>).</p>
      </sec>
    </sec>
    <sec>
      <title>3.3. Quality of the feature selection</title>
      <p>The (balanced) prediction <italic>accuracy</italic> of a classifier is the mean of <italic>sensitivity</italic> and <italic>specificity</italic>. The <italic>stability</italic> of the signature was determined as follows: the dataset was split into 10 subsets, each containing 90% of the samples, and the feature selection approach was applied to each subset, resulting in 10 signatures. The stability was the average similarity over all pairs of signatures. We used the similarity measure proposed by Lustgarten and colleagues, since (i) it is adjusted for the commonality of subsets obtained by chance only, and (ii) it allows to compare signatures of different sizes (Lustgarten et al., <xref rid="B38" ref-type="bibr">2009</xref>). The performance-robustness trade-off (hereafter <italic>performance</italic>) was computed as the harmonic mean of <italic>accuracy</italic> and <italic>stability</italic> (Determan, <xref rid="B15" ref-type="bibr">2015</xref>).</p>
    </sec>
    <sec>
      <title>3.4. Compared feature selection methods</title>
      <sec>
        <title>3.4.1. Filter methods</title>
        <p>Features were filtered according to their VIP value from PLS-DA, at a threshold of either 1 or 1.5.</p>
      </sec>
      <sec>
        <title>3.4.2. Wrapper methods</title>
        <p>We implemented recursive feature elimination (RFE) for SVM as described in Guyon et al. (<xref rid="B29" ref-type="bibr">2002</xref>). We used a 50 bootstrap resampling strategy (identical to <italic>biosigner</italic>), and removed the 20% features with highest ranks at each iteration. The subset giving the best prediction accuracy was selected. The same approach was also implemented for PLS-DA and Random Forest. For each classifier, the machine learning parameters and feature ranking metrics are identical to those from the <italic>biosigner</italic> algorithm, as described above.</p>
      </sec>
      <sec>
        <title>3.4.3. Embedded methods</title>
        <p>Prediction analysis for microarrays (PAM; also called nearest shrunken centroids), sparse PLS-DA, and Lasso/Elastic net were performed with the the <italic>pamr</italic> (Hastie et al., <xref rid="B30" ref-type="bibr">2014</xref>), <italic>spls</italic> (Chung et al., <xref rid="B14" ref-type="bibr">2013</xref>), and <italic>glmnet</italic> (Friedman et al., <xref rid="B21" ref-type="bibr">2010</xref>) R packages, respectively.</p>
      </sec>
    </sec>
    <sec>
      <title>3.5. Software</title>
      <p>The <italic>biosigner</italic> package was written in R (R Core Development Team, 2015; version 3.2.2) and is available (<ext-link ext-link-type="uri" xlink:href="http://bioconductor.org/packages/biosigner">http://bioconductor.org/packages/biosigner</ext-link>) from the Bioconductor repository (Gentleman et al., <xref rid="B22" ref-type="bibr">2004</xref>). It includes the <italic>diaplasma</italic> LC-HRMS metabolomics dataset. The package was run on a laptop computer (Windows 7; Intel Core i5 2.6 GHz processor; 8 GB RAM). The <italic>biosigner</italic> algorithm is also available with a graphical interface, as a Galaxy module within the <italic>Workflow4Metabolomics.org</italic> online resource for computational metabolomics (<ext-link ext-link-type="uri" xlink:href="http://workflow4metabolomics.org">http://workflow4metabolomics.org</ext-link>; Giacomoni et al., <xref rid="B23" ref-type="bibr">2015</xref>).</p>
    </sec>
  </sec>
  <sec id="s4">
    <title>4. Results</title>
    <sec>
      <title>4.1. Development of the <italic>biosigner</italic> algorithm</title>
      <p>We developed a new wrapper algorithm to select features which significantly improve the prediction of any binary classifier (see Section 2 and Figure <xref ref-type="fig" rid="F1">1</xref>). A feature subset <italic>S</italic><sub><italic>f</italic></sub> is declared significant if the predictions on test subsets (generated by resampling) are less accurate after randomly permuting the intensities of all features in <italic>S</italic><sub><italic>f</italic></sub> (Figure <xref ref-type="fig" rid="F2">2</xref>). The dataset is then restricted to the significant features and the procedure is iterated until the set of significant features remains unchanged (i.e., corresponds to the final signature), or until there is no feature left in the dataset to be tested (<italic>Theory</italic> section and Figure <xref ref-type="fig" rid="F1">1</xref>). The algorithm was wrapped around three machine learning approaches, namely Partial Least Squares Discriminant Analysis (PLS-DA), Random Forest, and Support Vector Machine (SVM), which rely on specific mathematical backgrounds (latent variables, decision trees, and kernel methods, respectively). For each classifier, the <italic>biosigner</italic> algorithm therefore returns a stable final <italic>S</italic> signature (possibly empty), in addition to several tiers (from <italic>A</italic> to <italic>E</italic>) corresponding to the features discarded during one of the previous iterations (e.g., features from the <italic>A</italic> tier were selected in all but the last iteration).</p>
    </sec>
    <sec>
      <title>4.2. Evaluation on published metabolomics and transcriptomics datasets</title>
      <p>We addressed the performance of the <italic>biosigner</italic> algorithm by analyzing the signatures obtained on two metabolomics and one transcriptomics real datasets. We started with a well-annotated human metabolomics dataset, in which the concentrations of 109 metabolites have been measured in urine samples from a cohort of 183 adult volunteers by using liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS, Thevenot et al., <xref rid="B59" ref-type="bibr">2015</xref>). A previous study of the physiological concentration differences between males and females using this <italic>sacurine</italic> dataset (Thevenot et al., <xref rid="B59" ref-type="bibr">2015</xref>) has shown that: (i) no specific gender clusters were observed by Principal Component Analysis (PCA), (ii) 45 metabolites had a significant difference of medians between genders (with Mann-Whitney <italic>U</italic>-tests and a False Discorvery Rate threshold of 5%), and (iii) PLS-DA modeling of <italic>gender</italic> had a significant <italic>Q</italic>2<italic>Y</italic> value of 0.58 (metric between 0 and 1 estimating the prediction performance by cross-validation; see Section 3). By applying the <italic>biosigner</italic> algorithm, signatures consisting of 2 (Random Forest) or 3 (PLS-DA, SVM) metabolites (i.e., less than 3% of the initial features) were identified (Figure <xref ref-type="fig" rid="F3">3A</xref>). Testosterone glucuronide was common to all 3 signatures, and oxoglutaric acid and p-anisic acid to 2 of them. All selected metabolites had a clearcut difference of intensities between males and females (Figure <xref ref-type="fig" rid="F4">4A</xref>). Prediction accuracies of the models restricted to the signatures were all superior or equal to the models trained on the full dataset (Table <xref ref-type="table" rid="T1">1</xref>).</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold><italic>biosigner</italic> discovery of molecular signatures from biological and clinical omics datasets</bold>. <bold>(A,B,D)</bold> The <italic>sacurine, spikedApples</italic>, and <italic>diaplasma</italic> metabolomics datasets result from the LC-HRMS analysis of, respectively, urines from male or female adult volunteers (Thevenot et al., <xref rid="B59" ref-type="bibr">2015</xref>), control apples or apples spiked with a mixture of known compounds (Franceschi et al., <xref rid="B20" ref-type="bibr">2012</xref>), and plasma from type 1 or 2 diabetic patients (see Section 3). <bold>(C)</bold> The <italic>leukemia</italic> transcriptomics dataset has been obtained by microarray analysis of bone marrow from patients with acute lymphoblastic or myeolid leukemia (Golub et al., <xref rid="B25" ref-type="bibr">1999</xref>). The <italic>biosigner</italic> signatures of <italic>gender</italic> (<italic>sacurine</italic> dataset), <italic>spiking</italic> (<italic>spikeApples</italic>), <italic>ALL/AML</italic> leukemia (<italic>leukemia</italic>), and diabetes <italic>type</italic> (<italic>diaplasma</italic>) obtained independantly by each of the 3 classifiers are shown (for <italic>diaplasma</italic>, the extended signatures up to tier <italic>A</italic> are displayed). The <italic>S</italic> tier corresponds to the final signature, i.e., metabolites which passed all the selection iterations determining whether the candidate variables significantly improve the model prediction. In contrast, metabolites from the other tiers were discarded during all but the last (<italic>A</italic>) or previous (<italic>B</italic> to <italic>E</italic>) iterations. RF, Random Forest.</p>
        </caption>
        <graphic xlink:href="fmolb-03-00026-g0003"/>
      </fig>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p><bold>Individual boxplots of the features selected by at least one of the classification methods</bold>. <bold>(A–C)</bold> Features specifically selected by a single classifier are colored (<italic>red</italic> for PLS-DA, <italic>green</italic> for Random Forest, and <italic>blue</italic> for SVM). <bold>(D)</bold> For the <italic>diaplasma</italic> dataset, two representative features from the <italic>A</italic> PLS-DA tier are also displayed. M/F, male/female; ctrl, control; ALL/AML, acute lymphoblastic/myeloid leukemia; T1/T2, type 1/type 2 diabetes.</p>
        </caption>
        <graphic xlink:href="fmolb-03-00026-g0004"/>
      </fig>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p><bold>Molecular signatures extracted by <italic>biosigner</italic> from metabolomics and transcriptomics biological and clinical datasets, and prediction accuracies of the corresponding models before and after feature selection</bold>.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr style="border-bottom: thin solid #000000;">
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1"/>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>
                  <italic>sacurine</italic>
                </bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>
                  <italic>spikedApples</italic>
                </bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>
                  <italic>leukemia</italic>
                </bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>
                  <italic>diaplasma</italic>
                </bold>
              </th>
            </tr>
            <tr style="border-bottom: thin solid #000000;">
              <th valign="top" align="left" rowspan="1" colspan="1">
                <bold>Systems level</bold>
              </th>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1"/>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Metabolomics</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Metabolomics</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Tanscriptomics</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Metabolomics</bold>
              </th>
            </tr>
            <tr>
              <th valign="top" align="left" rowspan="1" colspan="1">
                <bold>Groups</bold>
              </th>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1"/>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>male/female</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>control/spiked</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>ALL/AML</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>type 1/type 2</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Samples</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">183</td>
              <td valign="top" align="center" rowspan="1" colspan="1">20</td>
              <td valign="top" align="center" rowspan="1" colspan="1">72</td>
              <td valign="top" align="center" rowspan="1" colspan="1">69</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Variables</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">109</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1632</td>
              <td valign="top" align="center" rowspan="1" colspan="1">7129</td>
              <td valign="top" align="center" rowspan="1" colspan="1">5501</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Sample/variable ratio</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">1.7</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.012</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.013</td>
            </tr>
            <tr style="border-bottom: thin solid #000000;">
              <td valign="top" align="left" rowspan="1" colspan="1">Time (min)</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">0.4</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.4</td>
              <td valign="top" align="center" rowspan="1" colspan="1">4.8</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3.5</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">PLS-DA</td>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Signature S</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Random forest</td>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
            </tr>
            <tr style="border-bottom: thin solid #000000;">
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">SVM</td>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">PLS-DA</td>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">5</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">5</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Signature AS</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Random forest</td>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
            </tr>
            <tr style="border-bottom: thin solid #000000;">
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">SVM</td>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">8</td>
              <td valign="top" align="center" rowspan="1" colspan="1">20</td>
              <td valign="top" align="center" rowspan="1" colspan="1">5</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">Full</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.87</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.81 (ns)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.95</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.83</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">PLS-DA</td>
              <td valign="top" align="left" rowspan="1" colspan="1">AS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.88</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.88</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.9</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <bold>S</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.89</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>1</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.87</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.91</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">Full</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.86</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.92</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.92</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.81</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Accuracy</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Random forest</td>
              <td valign="top" align="left" rowspan="1" colspan="1">AS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.87</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.93</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.82</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <bold>S</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.86</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.99</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.92</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.81</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">Full</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.88</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.84</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.93</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.83</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">SVM</td>
              <td valign="top" align="left" rowspan="1" colspan="1">AS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.88</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.97</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.94</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.69</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <bold>S</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.89</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.86</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.95</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>na</bold>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p><italic>The accuracies of the models trained on the final S signatures are in bold. na: for the diaplasma dataset, no feature was selected as significant in the last iteration with the SVM classifier; ns: the Q2Y value of the PLS-DA classifier on the full spikedApples dataset is not significant indicating that the model before feature selection is overfitted</italic>.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>We then studied a recently published metabolomics dataset spiked with known compounds (Franceschi et al., <xref rid="B20" ref-type="bibr">2012</xref>). The <italic>spikedApples</italic> dataset results from the LC-HRMS analysis of groups of apples which have been spiked with various concentrations of 7 endogenous metabolites and 2 exogenous compounds. The peak table used in this study consists of two groups of 10 apple samples (<italic>control</italic> and <italic>spiked</italic>), and 1632 features (among which 22 were identified by the authors as originating from the spiked molecules; Franceschi et al., <xref rid="B20" ref-type="bibr">2012</xref>). Preliminary modeling of the <italic>control</italic> vs. <italic>spiked</italic> response by PLS-DA with the full dataset indicated that the <italic>Q</italic>2<italic>Y</italic> was not significant: feature selection was therefore mandatory to avoid overfitting (Table <xref ref-type="table" rid="T1">1</xref>). The <italic>biosigner</italic> algorithm identified complementary signatures of 1 or 2 features (Figure <xref ref-type="fig" rid="F3">3B</xref>). Classifiers trained on the dataset restricted to the signatures outperformed the models trained on the full dataset. Interestingly, the single features selected by PLS-DA and Random Forest corresponded to cyanidin-3-galactoside and a potassium adduct of phloridzin, respectively, which both belong to the list of expected discriminating metabolites: the former is absent from the natural matrix (<italic>control</italic> group), and the concentration of the latter is increased up to 80% in the <italic>spiked</italic> group (Franceschi et al., <xref rid="B20" ref-type="bibr">2012</xref>; Figure <xref ref-type="fig" rid="F4">4B</xref>). Surprisingly, the two features selected by SVM are less concentrated in the <italic>spiked</italic> group (Figure <xref ref-type="fig" rid="F4">4B</xref>). It should be noted, however, that such a decrease in concentrations was found significant by univariate hypothesis testing for a total of 9 features (including 722.5/619.1), compared with 17 features with significantly increased concentrations. The high proportion (35%) of features with decreased concentrations among the discriminating signals may therefore explain why two of them have been included in the SVM classification rule.</p>
      <p>Finally, to demonstrate that our approach can be applied to other omics data, we analyzed the reference transcriptomics dataset resulting from the microarray analysis of bone marrow samples from 72 leukemia patients (Golub et al., <xref rid="B25" ref-type="bibr">1999</xref>). Preliminary univariate hypothesis testing indicated that 1154 out of the 7129 features were significant for median difference between the lymphoblastic and myeloid groups. In addition, the two groups were clearly visible on the score plots from PLS-DA, but not PCA (data not shown). Our algorithm identified signatures from 1 to 2 gene probes (Figures <xref ref-type="fig" rid="F3">3C</xref>, <xref ref-type="fig" rid="F4">4C</xref>). Random Forest and SVM (but not PLS-DA) models trained on the signatures had superior or equal prediction accuracies than the classifiers trained on the full dataset (Table <xref ref-type="table" rid="T1">1</xref>). The four selected features ranked 1st, 5th, 7th, and 12th in the list of significant variables by univariate hypothesis testing, ordered by increasing <italic>p</italic>-values. Three of them, cystatin C, zyxin, and CD33, were also part of the 50 gene signature selected by Golub and colleagues on the basis of a filter metric derived from the Student's statistic (Golub et al., <xref rid="B25" ref-type="bibr">1999</xref>).</p>
    </sec>
    <sec>
      <title>4.3. Application to the discovery of signatures discriminating type 1 and type 2 diabetic patients</title>
      <p>We applied our methodology to the study of metabolomics signatures between type 1 and type 2 diabetes mellitus. Plasma samples from 69 diabetic patients were analyzed by LC-HRMS, and a peak table containing 5501 features was obtained after file preprocessing (see Section 3). Seven hundred features were found significant by univariate hypothesis testing. It should be noted that, because type 2 patients were significantly older than type 1 individuals in this cohort (as in the general population of diabetic patients), some of the observed variations may be the result of physiological aging (see Section 5). Unsupervised analysis by PCA did not evidence any clustering according to diabetic <italic>type</italic>, in contrast to PLS-DA modeling which resulted in a significant <italic>Q</italic>2<italic>Y</italic> value of 0.46. By further applying the <italic>biosigner</italic> algorithm, signatures of 1 and 2 features were obtained with the PLS-DA and Random Forest classifiers, respectively (Figure <xref ref-type="fig" rid="F3">3D</xref>), in an average computation time of 3.4 min pro classifier on a laptop computer. The two features were highly significant by hypothesis testing of difference between <italic>type</italic> medians (<italic>p</italic> &lt; 10<sup>−7</sup> and <italic>p</italic> &lt; 10<sup>−6</sup>, respectively; Figure <xref ref-type="fig" rid="F4">4D</xref>), and to a lesser extent by testing of correlation with <italic>age</italic> (<italic>p</italic> &lt; 10<sup>−4</sup> and <italic>p</italic> &lt; 10<sup>−3</sup>) or <italic>body mass index</italic> (<italic>p</italic> &lt; 10<sup>−2</sup> and <italic>p</italic> &lt; 5 × 10<sup>−2</sup>). Surprisingly, the <italic>S</italic> signature from SVM was empty (i.e., no feature was selected as relevant in the last extraction round). We therefore investigated the features from the antepenultimate (<italic>A</italic>) tier (Figure <xref ref-type="fig" rid="F3">3D</xref>): variables from the <italic>A</italic> SVM signature were distinct from PLS-DA and Random Forest, and the accuracy of the SVM model restricted to the <italic>A</italic> signature decreased (from 83% to 69%; Table <xref ref-type="table" rid="T1">1</xref>). In contrast, accuracies of the PLS-DA and Random Forest models restricted to the <italic>S</italic> signatures (91% and 81%, respectively) were both superior or equal to the models trained on the full dataset (83% and 81%).</p>
    </sec>
    <sec>
      <title>4.4. Stability of the signatures and sensitivity/specificity of the selection</title>
      <p>The influence of bootstraping on the <italic>stability</italic> of the <italic>S</italic> and <italic>S+A</italic> signatures was assessed for each of the 4 datasets by increasing the number of bootstraps from 5 to 200, and looking for differences in stability by using repeated measure ANOVA. No significant difference was observed above 20 bootstraps for PLS-DA and SVM, and 10 bootstraps for Random Forest. The number of 50 bootstraps was thus selected as the default value in <italic>biosigner</italic>, and used in all computations.</p>
      <p>To assess the <italic>sensitivity</italic> and the <italic>specificity</italic> of the methodology, datasets containing known discriminant variables were simulated (see Supplementary Material). To avoid making hypotheses about the structure of an “omics” dataset (e.g., noise, intensity distribution, etc.), we started from the real metabolomics and transcriptomics datasets and removed all features which were significant by univariate hypothesis testing (Wehrens and Franceschi, <xref rid="B65" ref-type="bibr">2012</xref>). We then increased the discriminant capacity of one of the features by multiplying the intensities in one of the sample groups by a factor. The factor was chosen so that the target feature was still not detected at a False Discovery Rate of 0.05. By applying this methodology to our transcriptomics and metabolomics datasets, we observed that, despite the high ratio of variables to samples (up to 100 for the <italic>leukemia</italic> dataset), the target feature was detected with a high sensitivity (from 60% up to 100% in the union of the three classifier signatures) and a high specificity (more than 98%; see Supplementary Material).</p>
    </sec>
    <sec>
      <title>4.5. Comparison with alternative feature selection methods</title>
      <p>We compared our algorithm with 6 alternative approaches for feature selection, namely VIP filtering (at the 1 and 1.5 thresholds; Mehmood et al., <xref rid="B42" ref-type="bibr">2012</xref>), recursive feature elimination wrapper (RFE; Guyon et al., <xref rid="B29" ref-type="bibr">2002</xref>), and 4 embedded methods (prediction analysis of microarray, PAM, also called nearest shrunken centroids, Tibshirani et al., <xref rid="B61" ref-type="bibr">2002</xref>, sparse PLS-DA, Chun and Keles, <xref rid="B13" ref-type="bibr">2010</xref>, Lasso, Tibshirani, <xref rid="B60" ref-type="bibr">1996</xref>, and Elastic Net, Zou and Hastie, <xref rid="B69" ref-type="bibr">2005</xref>). In particular, to achieve a comprehensive comparison between the <italic>biosigner</italic> and RFE wrapper approaches, we applied the RFE methodology not only to SVM (as initially described, Guyon et al., <xref rid="B29" ref-type="bibr">2002</xref>) but also to PLS-DA and Random Forest. For each algorithm, the <italic>accuracy</italic> of the final model, the <italic>size</italic> and <italic>stability</italic> of the signature, as well as the <italic>performance</italic> (harmonic mean between <italic>accuracy</italic> and <italic>stability</italic>) were computed for each of the 4 datasets, and the running <italic>time</italic> on a laptop computer was recorded (Table <xref ref-type="table" rid="T2">2</xref>). The best <italic>performances</italic> were achieved by using the <italic>biosigner</italic> algorithm: whereas higher prediction <italic>accuracies</italic> could be obtained by regularized methods such as Elastic Net, the signatures from <italic>biosigner</italic> were usually more stable. Surprisingly, the stability of the Random Forest and SVM <italic>biosigner</italic> signatures on the <italic>spikedApples</italic> dataset (and also of the SVM signature on the <italic>diaplasma</italic> dataset) was low. The variability observed with the <italic>spikedApples</italic> dataset may be due to the small number of samples (10 in each group) in addition to the very small proportion of discriminating signals. The median and interquartile metric values for the <italic>sacurine, leukemia</italic> and <italic>diaplasma</italic> datasets are plotted on Figure <xref ref-type="fig" rid="F5">5</xref>. We see that <italic>biosigner</italic> selects restricted signatures, which are usually of high stability and provide high prediction accuracy.</p>
      <table-wrap id="T2" position="float">
        <label>Table 2</label>
        <caption>
          <p><bold>Comparison of <italic>biosigner</italic> with alternative feature selection methods</bold>.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1"/>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Accuracy</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Stability</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Performance</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Number of features</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Time (min)</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr style="border-bottom: thin solid #000000;">
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">sacu spik leuk diap</td>
              <td valign="top" align="center" rowspan="1" colspan="1">sacu spik leuk diap</td>
              <td valign="top" align="center" rowspan="1" colspan="1">sacu spik leuk diap</td>
              <td valign="top" align="center" rowspan="1" colspan="1">sacu spik leuk diap</td>
              <td valign="top" align="center" rowspan="1" colspan="1">sacu spik leuk diap</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">VIP filter</td>
              <td valign="top" align="center" rowspan="1" colspan="1">≥1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.87 <bold>1.00 0.97</bold> 0.85</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.56 0.50 0.54 0.57</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.68 0.67 0.70 0.68</td>
              <td valign="top" align="center" rowspan="1" colspan="1">36 332 2012 1344</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.1 0.3 2.1 0.9</td>
            </tr>
            <tr style="border-bottom: thin solid #000000;">
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">≥1.5</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.88 <bold>1.00</bold> 0.96 <bold>0.91</bold></td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.90 0.70 0.76 0.73</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.89 0.83 0.85 0.81</td>
              <td valign="top" align="center" rowspan="1" colspan="1">5 72 418 345</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.1 0.4 2.1 0.9</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">PLS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.88 <bold>1.00</bold> 0.84 0.90</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.97 <bold>1.00</bold> 0.64 <bold>0.98</bold></td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.92 <bold>1.00</bold> 0.73 <bold>0.94</bold></td>
              <td valign="top" align="center" rowspan="1" colspan="1">4 <bold>1 2 2</bold></td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.7 1.0 8.2 3.1</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>biosigner</italic>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">RF</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.87 0.90 0.90 0.77</td>
              <td valign="top" align="center" rowspan="1" colspan="1"><bold>0.98</bold> 0.11 0.75 0.94</td>
              <td valign="top" align="center" rowspan="1" colspan="1"><bold>0.92</bold> 0.20 0.82 0.85</td>
              <td valign="top" align="center" rowspan="1" colspan="1"><bold>2 1 2</bold> 3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.0 0.8 13.1 4.9</td>
            </tr>
            <tr style="border-bottom: thin solid #000000;">
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">SVM</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.87 0.67 0.92 0.75</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.95 0.07 <bold>1.00</bold> 0.09</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.91 0.12 <bold>0.96</bold> 0.16</td>
              <td valign="top" align="center" rowspan="1" colspan="1">4 1 2 2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.2 0.7 7.8 2.7</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">PLS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.86 0.90 0.95 0.88</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.93 0.43 0.85 0.83</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.89 0.58 0.90 0.86</td>
              <td valign="top" align="center" rowspan="1" colspan="1">6 539 480 414</td>
              <td valign="top" align="center" rowspan="1" colspan="1">6.8 2.0 7.8 1.0</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">RFE</td>
              <td valign="top" align="center" rowspan="1" colspan="1">RF</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.88 0.95 <bold>0.97</bold> 0.88</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.72 0.17 0.34 0.71</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.79 0.28 0.51 0.79</td>
              <td valign="top" align="center" rowspan="1" colspan="1">16 566 1705 101</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.7 <bold>0.0</bold> 0.2 0.1</td>
            </tr>
            <tr style="border-bottom: thin solid #000000;">
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">SVM</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.92 0.95 <bold>0.97</bold> 0.80</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.52 0.90 0.86 0.69</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.66 0.92 0.91 0.74</td>
              <td valign="top" align="center" rowspan="1" colspan="1">28 41 438 91</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2.5 1.1 7.4 2.4</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">PAM</td>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">0.83 <bold>1.00</bold> 0.95 0.81</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.35 <bold>1.00</bold> 0.69 0.54</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.49 <bold>1.00</bold> 0.80 0.65</td>
              <td valign="top" align="center" rowspan="1" colspan="1">64 <bold>1</bold> 1485 1575</td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.0 0.0 0.1 0.0</bold>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">sPLS</td>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">0.92 <bold>1.00</bold> 0.94 0.88</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.45 0.80 0.39 0.76</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.60 0.89 0.55 0.82</td>
              <td valign="top" align="center" rowspan="1" colspan="1">87 131 3280 685</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.5 1.6 75.3 15.5</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Lasso</td>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1"><bold>0.94 1.00</bold> 0.92 0.85</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.51 <bold>1.00</bold> 0.67 0.64</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.66 <bold>1.00</bold> 0.78 0.73</td>
              <td valign="top" align="center" rowspan="1" colspan="1">35 <bold>1</bold> 20 11</td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.0 0.0 0.1 0.0</bold>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Elast. Net</td>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">0.94 <bold>1.00</bold> 0.95 0.85</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.48 1.00 0.79 0.67</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.64 1.00 0.86 0.75</td>
              <td valign="top" align="center" rowspan="1" colspan="1">42 2 60 69</td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>0.0 0.0 0.1 0.0</bold>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p><italic>The metrics obtained with the sacurine (sacu), spikedApples (spik), leukemia (leuk), and diaplasma (diap) datasets are shown (performance is the harmonic mean between the accuracy and the stability). For each metric and each dataset, the method(s) with optimum value is/are in bold. Elast. Net, Elastic Net; PAM, prediction analysis of microarrays (also called nearest shrunken centroids); RF, Random Forest; RFE, recursive feature elimination; sPLS, sparse PLS-DA; VIP filter, filtering by the variable of importance in projection metric from PLS-DA</italic>.</p>
        </table-wrap-foot>
      </table-wrap>
      <fig id="F5" position="float">
        <label>Figure 5</label>
        <caption>
          <p><bold>Comparison of <italic>biosigner</italic> with alternative feature selection approaches</bold>. Metric values are from Table <xref ref-type="table" rid="T2">2</xref>: the median and interquartile range for the <italic>sacurine, leukemia</italic>, and <italic>diaplasma</italic> datasets are indicated as colored symbols and grays arrows, respectively. PAM: prediction analysis of microarrays (also called nearest shrunken centroids); RF, Random Forest; RFE, recursive feature elimination; filter VIP, filtering by the <italic>variable importance in projection</italic> metric from PLS-DA.</p>
        </caption>
        <graphic xlink:href="fmolb-03-00026-g0005"/>
      </fig>
    </sec>
    <sec>
      <title>4.6. Implementations of the <italic>biosigner</italic> methodology into an R/Bioconductor package and a Galaxy/Workflow4metabolomics module</title>
      <p>To share the algorithm and its source code with the bioinformatics community, a <italic>biosigner</italic> R package (<ext-link ext-link-type="uri" xlink:href="http://bioconductor.org/packages/biosigner">http://bioconductor.org/packages/biosigner</ext-link>) was published on the Bioconductor repository (Gentleman et al., <xref rid="B22" ref-type="bibr">2004</xref>). Furthermore, to provide a graphical interface for the experimenter community, we developed a Galaxy module which was integrated into the Worfklow4Metabolomics (W4M) online infrastructure for computational metabolomics (<ext-link ext-link-type="uri" xlink:href="http://workflow4metabolomics.org">http://workflow4metabolomics.org</ext-link>; Giacomoni et al., <xref rid="B23" ref-type="bibr">2015</xref>). The full <italic>history</italic> (i.e., workflow and associated input and output data) of the statistical analysis of the <italic>diaplasma</italic> dataset described in this study is publicly available on W4M, with the W4M00003 reference number.</p>
    </sec>
  </sec>
  <sec id="s5">
    <title>5. Discussion</title>
    <p>We have developed a new algorithm for feature selection, named <italic>biosigner</italic>, which iteratively removes subsets of features that do not significantly improve the prediction accuracy of the model. Compared with alternative wrapper approaches (such as recursive feature elimination) based on the prediction accuracy only, <italic>biosigner</italic> selects feature subsets which <italic>significantly</italic> improve this prediction. The two main innovations of the algorithm are: (1) the significance of a feature subset is estimated by comparing the model predictions before and after random permutation of the intensities of these features in test subsets generated by resampling, and (2) the whole feature selection procedure is repeated recursively until all features of the selected subset are found significant, or until there is no feature left to be tested. Since permutations occur only in the test subsets, the number of models to be built is limited and the algorithm is fast (only a few minutes on a laptop for datasets of several thousands of variables). <italic>biosigner</italic> returns (i) the final <italic>S</italic> signature, (ii) the tiers (<italic>A</italic> to <italic>E</italic>) containing the features discarded during one of the previous selection rounds, and iii) the models trained on the <italic>S</italic> (and <italic>S+A</italic>) signatures to be used for future predictions.</p>
    <p>The term <italic>significance</italic> is usually associated in the statistical literature to a hypothesis test and to a so called <italic>null</italic> hypothesis. Here, we do not assess the significance of the model itself, but we rather estimate the influence of a given subset of features on the prediction accuracy of the model. However, since the number of selected features in the final signature is restricted (i.e., smaller than the number of samples), the risk of overfitting is limited. Also, since the training and testing subsets are not set apart during the full procedure (because of the resampling between the selection rounds), the returned performance of the final model may be slightly over-optimistic. External validation on a new dataset is therefore required to refine the estimation of the model accuracy (Esbensen and Geladi, <xref rid="B19" ref-type="bibr">2010</xref>).</p>
    <p>By wrapping the <italic>biosigner</italic> algorithm around 3 binary classifiers with specific mathematical backgrounds (PLS-DA, Random Forest, and SVM), we observed on three published metabolomics and transcriptomics datasets that the signatures had some degree of similarity (e.g., at least one of the features in the tiers <italic>S+A</italic> was common to at least two classifiers), but also included classifier-specific features. For example, with the <italic>spikedApples</italic> dataset, SVM selects features with opposite variations compared with PLS-DA and Random Forest. The complementarity between the signatures is in agreement with several recent studies reporting classifier-specific results depending on the structure of the dataset (correlation between features, noise, proportion of zeros intensities; Christin et al., <xref rid="B12" ref-type="bibr">2013</xref>; Tarca et al., <xref rid="B57" ref-type="bibr">2013</xref>; Determan, <xref rid="B15" ref-type="bibr">2015</xref>). The discrepancies come from the specific weights each classifier assigns the variables (or the samples in the case of SVM). In fact, if the same ranking metric is used for all classifiers in our algorithm, signatures become more similar (see Supplementary Material). The use of classifier-specific metrics in <italic>biosigner</italic> (i.e., VIP for PLS-DA, variable importance for Random Forest, and squared weights for SVM) should therefore increase the chances of discovering distinct features of interest.</p>
    <p>The signatures obtained with the three datasets were short (up to 3 features), and the restriction to these signatures usually resulted in higher prediction accuracies of the classifiers (except for the PLS-DA model on the <italic>leukemia</italic> dataset). Importantly, restricting to small signatures also helped avoiding the risk of overfitting: for instance, the high performance of PLS-DA model of the <italic>spikedApples</italic> full dataset was not significant, contrary to the model built on the single feature signature.</p>
    <p>The selected molecules were also shown to be in good agreement with the reported results: the 2 features from the <italic>spikedApples</italic> PLS-DA and Random Forest signatures were related to the spiked compounds (Franceschi et al., <xref rid="B20" ref-type="bibr">2012</xref>), and the 3 gene probes selected by PLS-DA and SVM on <italic>leukemia</italic> dataset were already included in the published signature (Golub et al., <xref rid="B25" ref-type="bibr">1999</xref>). Interestingly, the probe selected by Random Forest, myeloperoxidase, is a cytochemical marker for the diagnosis (and also potentially the prognosis) of acute myeloid leukemia (AML; Matsuo et al., <xref rid="B41" ref-type="bibr">2003</xref>). Although myeloperoxidase would also have been included in the published signature if the full dataset had been used for training (as in this study) instead of the 38 sample subset (Golub et al., <xref rid="B25" ref-type="bibr">1999</xref>), this feature would have been ranked only in the 24th position. Altogether, the above results show that <italic>biosigner</italic> selects relevant signatures providing high and significant prediction accuracy of the classifiers.</p>
    <p>Comparison with alternative feature selection strategies revealed that <italic>biosigner</italic> specifically selected stable signatures. In contrast, Lasso and Elastic net classifiers showed higher accuracy but the signatures were more prone to instability, in agreement with a previous analysis of 4 transcriptomics datasets (Haury et al., <xref rid="B31" ref-type="bibr">2011</xref>): such methods can therefore be of high interest when classification accuracy (instead of feature selection) is the primary goal of the study. For feature selection, however, stability is critical since the subsequent validation steps leading to the diagnostic product will focus on the selected features only. Surprisingly, the stabilities of the <italic>biosigner</italic> SVM signatures were low for two of the datasets (<italic>diaplasma</italic> and <italic>spikedApples</italic>). This suggests that the combination of backward selection and feature ranking with the SVM square weights may result with some datasets in the elimination of relevant features during the first selection rounds.</p>
    <p>The <italic>biosigner</italic> signatures were of restricted size. Such small signatures are pivotal for diagnosis purposes, where only a limited number of candidates are expected to enter the validation phase. The size of the signatures may be a consequence of the stringency of our selection algorithm, but also of the structure of the datasets analyzed in this study, where a very few variables are sufficient to efficiently discriminate between the two sample groups. It should be noted that the criterion for feature selection focuses on the added value of the tested features for model performance. Hence, additional features with equal relevance for prediction may not appear in the final <italic>S</italic> signature. As an example, only a fraction of the features related to the spiked compounds in the <italic>spikedApples</italic> dataset is selected. If an extended view of discriminating candidates is required, it may be of interest to look also at the <italic>S+A</italic> signature. An alternative is to re-run the <italic>biosigner</italic> algorithm after discarding the <italic>S</italic> signature, or after increasing the value of the α significance threshold.</p>
    <p>We applied our methodology to address a new clinical question, namely the discovery of metabolomics signatures between type 1 and type 2 diabetic patients. The etiology of diabetes is complex (in particular the type 2, or insulino-resistant, form), and new biomarkers are needed for prognosis and diagnosis of the disease (Roberts et al., <xref rid="B48" ref-type="bibr">2014</xref>). We thus performed a metabolomics analysis of plasma samples from diabetic patients by LC-HRMS. In this cohort, type 2 patients are significantly older (<italic>p</italic> &lt; 10<sup>−8</sup>) and, to a lesser extent, have a higher <italic>body mass index</italic> (<italic>p</italic> &lt; 10<sup>−7</sup>) than type 1 patients. Matching (e.g., by <italic>age</italic>), however, would have resulted in a very restricted subset of only 14 patients, in which no type 2 vs. type 1 significant feature could be found by univariate testing nor <italic>biosigner</italic> feature selection. We therefore used in this study the full <italic>diaplasma</italic> dataset instead (63 samples and 5501 features). Two features were selected either in the PLS-DA or Random Forest signatures. Importantly, when these features were modeled by a combination of the 3 covariates (diabetic <italic>type, age</italic>, and <italic>body mass index</italic>), only the <italic>type</italic> effect was found significant by analysis of variance, thus emphasizing the putative value of these markers in the classification of diabetes. Interestingly, one of the features from the <italic>S+A</italic> PLS-DA signature (497.275/487) matched with an isotope of a taurochenodeoxycholic acid fragment (according to m/z ratio and retention time): diabetes-associated changes in bile acid metabolism have been reported (Prawitt et al., <xref rid="B46" ref-type="bibr">2011</xref>), and variation of the taurochenodeoxycholic acid concentration has very recently been described in urine of type 2 patients (Taylor et al., <xref rid="B58" ref-type="bibr">2014</xref>). The <italic>biosigner</italic> signature, which requires further validation by MS/MS experiments and confirmation in another cohort study where patients and controls are matched by <italic>age</italic>, may therefore highlight new candidates for diabetes screening and diagnosis.</p>
    <p>The <italic>biosigner</italic> algorithm is available as an R/Bioconductor package. As no clinical metabolomics dataset is currently available on Bioconductor to the best of our knowledge, we included the <italic>diaplasma</italic> LC-HRMS dataset into the package: this dataset should be useful for the benchmarking of new statistical and annotation algorithms. We also developed a Galaxy module which was integrated into the Workflow4metabolomics online infrastructure for computational metabolomics (W4M; Giacomoni et al., <xref rid="B23" ref-type="bibr">2015</xref>). Galaxy is a powerful open-source workflow manager enabling users to build their own workflow by selecting the tools and the parameter values via a graphical interface (Goecks et al., <xref rid="B24" ref-type="bibr">2010</xref>). Workflows and associated data inputs and outputs can be saved and shared, allowing fine tuning of parameters and reproducible research (Boekel et al., <xref rid="B5" ref-type="bibr">2015</xref>). The W4M infrastructure is therefore of high interest for experimenters to build, run, and reference reproducible LC-MS, GC-MS, and NMR workflows, for developers to compare and diffuse their tools, and also for teachers to organize hands-on sessions (since no software installation is required).</p>
    <p>In conclusion, the <italic>biosigner</italic> algorithm and the associated software tools should be of high value for biologists, practitioners, and biostatisticians, to identify robust biomarker signatures from large omics datasets for the development of new diagnostics.</p>
  </sec>
  <sec id="s6">
    <title>Author contributions</title>
    <p>PR developed the algorithm and co-wrote the article. ET implemented the R package and the Galaxy module, worked on the application of the method to metabolomics, preprocessed the <italic>diaplasma</italic> dataset, and co-wrote the article. LC-HRMS analysis and annotation of the plasma samples from the <italic>diaplasma</italic> dataset were performed by SB and CJ.</p>
  </sec>
  <sec id="s7">
    <title>Funding</title>
    <p>This work was supported by the Agence Nationale de la Recherche (ET: MetaboHUB national infrastructure for metabolomics and fluxomics, ANR-11-INBS-0010 grant) and the Seventh Framework Programme (PR; Biomargin project, grant agreement No 305499).</p>
    <sec>
      <title>Conflict of interest statement</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </sec>
</body>
<back>
  <ack>
    <p>The authors thank Pr Etienne Larger (Diabetology Department, Hôtel Dieu, Paris) for providing us with plasma samples from diabetic patients, Pierrick Roger for his help in the automated query of spectral databases during the annotation of the <italic>diaplasma</italic> dataset, and Claudine Rolley for helpful discussions.</p>
  </ack>
  <sec sec-type="supplementary-material" id="s8">
    <title>Supplementary material</title>
    <p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fmolb.2016.00026">http://journal.frontiersin.org/article/10.3389/fmolb.2016.00026</ext-link></p>
    <supplementary-material content-type="local-data">
      <media xlink:href="DataSheet1.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <ref-list>
    <title>References</title>
    <ref id="B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>A.</given-names></name><name><surname>Julia</surname><given-names>A.</given-names></name><name><surname>Beltran</surname><given-names>A.</given-names></name><name><surname>Vinaixa</surname><given-names>M.</given-names></name><name><surname>Diaz</surname><given-names>M.</given-names></name><name><surname>Ibanez</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Astream: an r package for annotating lc/ms metabolomic data</article-title>. <source>Bioinformatics</source><volume>27</volume>, <fpage>1339</fpage>–<lpage>1340</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btr138</pub-id><?supplied-pmid 21414990?><pub-id pub-id-type="pmid">21414990</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armitage</surname><given-names>E. G.</given-names></name><name><surname>Barbas</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Metabolomics in cancer biomarker discovery: current trends and future perspectives</article-title>. <source>J. Pharm. Biomed. Anal.</source>
<volume>87</volume>, <fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2013.08.041</pub-id><?supplied-pmid 24091079?><pub-id pub-id-type="pmid">24091079</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>In biomarkers we trust?</article-title>
<source>Nat. Biotechnol.</source>
<volume>23</volume>, <fpage>297</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1038/nbt0305-297</pub-id><?supplied-pmid 15765081?><pub-id pub-id-type="pmid">15765081</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>M.</given-names></name><name><surname>Rayens</surname><given-names>W.</given-names></name></person-group> (<year>2003</year>). <article-title>Partial least squares for discrimination</article-title>. <source>J. Chemometr.</source>
<volume>17</volume>, <fpage>166</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1002/cem.785</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boekel</surname><given-names>J.</given-names></name><name><surname>Chilton</surname><given-names>J. M.</given-names></name><name><surname>Cooke</surname><given-names>I. R.</given-names></name><name><surname>Horvatovich</surname><given-names>P. L.</given-names></name><name><surname>Jagtap</surname><given-names>P. D.</given-names></name><name><surname>Kall</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Multi-omic data analysis using galaxy</article-title>. <source>Nat. Biotechnol.</source><volume>33</volume>, <fpage>137</fpage>–<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3134</pub-id><?supplied-pmid 25658277?><pub-id pub-id-type="pmid">25658277</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boja</surname><given-names>E.</given-names></name><name><surname>Hiltke</surname><given-names>T.</given-names></name><name><surname>Rivers</surname><given-names>R.</given-names></name><name><surname>Kinsinger</surname><given-names>C.</given-names></name><name><surname>Rahbar</surname><given-names>A.</given-names></name><name><surname>Mesri</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Evolution of clinical proteomics and its role in medicine</article-title>. <source>J. Prot. Res.</source><volume>10</volume>, <fpage>66</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1021/pr100532g</pub-id><?supplied-pmid 20715861?><pub-id pub-id-type="pmid">20715861</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Boser</surname><given-names>B.</given-names></name><name><surname>Guyon</surname><given-names>I.</given-names></name><name><surname>Vapnik</surname><given-names>V.</given-names></name></person-group> (<year>1992</year>). <article-title>A training algorithm for optimal margin classifiers</article-title>, in <source>Fifth Annual Workshop on Computational Learning Theory</source> (<publisher-loc>Pittsburgh, PA</publisher-loc>), <fpage>144</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1145/130385.130401</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breiman</surname><given-names>L.</given-names></name></person-group> (<year>2001</year>). <article-title>Random forests</article-title>. <source>Mach. Learn.</source>
<volume>45</volume>, <fpage>5</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1023/A:1010933404324</pub-id><?supplied-pmid 27057518?><pub-id pub-id-type="pmid">27057518</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>M. P.</given-names></name><name><surname>Grundy</surname><given-names>W. N.</given-names></name><name><surname>Lin</surname><given-names>D.</given-names></name><name><surname>Cristianini</surname><given-names>N.</given-names></name><name><surname>Sugnet</surname><given-names>C. W.</given-names></name><name><surname>Furey</surname><given-names>T. S.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Knowledge-based analysis of microarray gene expression data by using support vector machines</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>97</volume>, <fpage>262</fpage>–<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.97.1.262</pub-id><?supplied-pmid 10618406?><pub-id pub-id-type="pmid">10618406</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>C.-C.</given-names></name><name><surname>Lin</surname><given-names>C.-J.</given-names></name></person-group> (<year>2011</year>). <article-title>Libsvm: a library for support vector machines</article-title>. <source>ACM Trans. Intell. Syst. Technol.</source>
<volume>2</volume>, <fpage>1</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1145/1961189.1961199</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Xie</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma</article-title>. <source>Mol. Cell. Proteom.</source><volume>10</volume>:<fpage>M110.004945</fpage>. <pub-id pub-id-type="doi">10.1074/mcp.m110.004945</pub-id><?supplied-pmid 21518826?><pub-id pub-id-type="pmid">21518826</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christin</surname><given-names>C.</given-names></name><name><surname>Hoefsloot</surname><given-names>H. C. J.</given-names></name><name><surname>Smilde</surname><given-names>A. K.</given-names></name><name><surname>Hoekman</surname><given-names>B.</given-names></name><name><surname>Suits</surname><given-names>F.</given-names></name><name><surname>Bischoff</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>A critical assessment of feature selection methods for biomarker discovery in clinical proteomics</article-title>. <source>Mol. Cell. Proteom.</source><volume>12</volume>, <fpage>263</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M112.022566</pub-id><?supplied-pmid 23115301?><pub-id pub-id-type="pmid">23115301</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>H.</given-names></name><name><surname>Keles</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Sparse partial least squares regression for simultaneous dimension reduction and variable selection</article-title>. <source>J. R. Stat. Soc. Ser. B (Statistical Methodol.)</source>
<volume>72</volume>, <fpage>3</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1111/j.1467-9868.2009.00723.x</pub-id><?supplied-pmid 20107611?><pub-id pub-id-type="pmid">20107611</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>D.</given-names></name><name><surname>Chun</surname><given-names>H.</given-names></name><name><surname>Keles</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <source>spls: Sparse Partial Least Squares (SPLS) Regression and Classification</source>. R package version 2.2-1.</mixed-citation>
    </ref>
    <ref id="B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Determan</surname><given-names>C. E.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2015</year>). <article-title>Optimal algorithm for metabolomics classification and feature selection varies by dataset</article-title>. <source>Int. J. Biol.</source>
<volume>7</volume>, <fpage>100</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.5539/ijb.v7n1p100</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz-Uriarte</surname><given-names>R.</given-names></name><name><surname>Alvarez de Andres</surname><given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Gene selection and classification of microarray data using random forest</article-title>. <source>BMC Bioinformatics</source>
<volume>7</volume>:<fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-7-3</pub-id><?supplied-pmid 22125385?><pub-id pub-id-type="pmid">16398926</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>W. B.</given-names></name><name><surname>Broadhurst</surname><given-names>D.</given-names></name><name><surname>Begley</surname><given-names>P.</given-names></name><name><surname>Zelena</surname><given-names>E.</given-names></name><name><surname>Francis-McIntyre</surname><given-names>S.</given-names></name><name><surname>Anderson</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry</article-title>. <source>Nat. Prot.</source><volume>6</volume>, <fpage>1060</fpage>–<lpage>1083</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2011.335</pub-id><?supplied-pmid 21720319?><pub-id pub-id-type="pmid">21720319</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>I.</given-names></name><name><surname>Johansson</surname><given-names>E.</given-names></name><name><surname>Kettaneh-Wold</surname><given-names>N.</given-names></name><name><surname>Wold</surname><given-names>S.</given-names></name></person-group> (<year>2001</year>). <source>Multi- and Megavariate Data Analysis. Principles and Applications</source>. <publisher-loc>Umea</publisher-loc>: <publisher-name>Umetrics Academy</publisher-name>.</mixed-citation>
    </ref>
    <ref id="B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esbensen</surname><given-names>K. H.</given-names></name><name><surname>Geladi</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Principles of proper validation: use and abuse of re-sampling for validation</article-title>. <source>J. Chemometr.</source>
<volume>24</volume>, <fpage>168</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1002/cem.1310</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franceschi</surname><given-names>P.</given-names></name><name><surname>Masuero</surname><given-names>D.</given-names></name><name><surname>Vrhovsek</surname><given-names>U.</given-names></name><name><surname>Mattivi</surname><given-names>F.</given-names></name><name><surname>Wehrens</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>A benchmark spike-in data set for biomarker identification in metabolomics</article-title>. <source>J. Chemometr.</source>
<volume>26</volume>, <fpage>16</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1002/cem.1420</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>J.</given-names></name><name><surname>Hastie</surname><given-names>T.</given-names></name><name><surname>Tibshirani</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Regularization paths for generalized linear models via coordinate descent</article-title>. <source>J. Stat. Softw.</source>
<volume>33</volume>, <fpage>1</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.18637/jss.v033.i01</pub-id><?supplied-pmid 20808728?><pub-id pub-id-type="pmid">20808728</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentleman</surname><given-names>R.</given-names></name><name><surname>Carey</surname><given-names>V.</given-names></name><name><surname>Bates</surname><given-names>D.</given-names></name><name><surname>Bolstad</surname><given-names>B.</given-names></name><name><surname>Dettling</surname><given-names>M.</given-names></name><name><surname>Dudoit</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Bioconductor: open software development for computational biology and bioinformatics</article-title>. <source>Genome Biol.</source><volume>5</volume>:<fpage>R80</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2004-5-10-r80</pub-id><?supplied-pmid 15461798?><pub-id pub-id-type="pmid">15461798</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giacomoni</surname><given-names>F.</given-names></name><name><surname>Le Corguillé</surname><given-names>G.</given-names></name><name><surname>Monsoor</surname><given-names>M.</given-names></name><name><surname>Landi</surname><given-names>M.</given-names></name><name><surname>Pericard</surname><given-names>P.</given-names></name><name><surname>Pétéra</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Workflow4metabolomics: a collaborative research infrastructure for computational metabolomics</article-title>. <source>Bioinformatics</source><volume>31</volume>, <fpage>1493</fpage>–<lpage>1495</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu813</pub-id><?supplied-pmid 25527831?><pub-id pub-id-type="pmid">25527831</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goecks</surname><given-names>J.</given-names></name><name><surname>Nekrutenko</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>J.</given-names></name><name><surname>Team</surname><given-names>T. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences</article-title>. <source>Genome Biol.</source>
<volume>11</volume>:<fpage>R86</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2010-11-8-r86</pub-id><?supplied-pmid 20738864?><pub-id pub-id-type="pmid">20738864</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golub</surname><given-names>T. R.</given-names></name><name><surname>Slonim</surname><given-names>D. K.</given-names></name><name><surname>Tamayo</surname><given-names>P.</given-names></name><name><surname>Huard</surname><given-names>C.</given-names></name><name><surname>Gaasenbeek</surname><given-names>M.</given-names></name><name><surname>Mesirov</surname><given-names>J. P.</given-names></name><etal/></person-group>. (<year>1999</year>). <article-title>Molecular classification of cancer: class discovery and class prediction by gene expression monitoring</article-title>. <source>Science</source><volume>286</volume>, <fpage>531</fpage>. <pub-id pub-id-type="doi">10.1126/science.286.5439.531</pub-id><?supplied-pmid 10521349?><pub-id pub-id-type="pmid">10521349</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>S. F.</given-names></name><name><surname>Chevallier</surname><given-names>O. P.</given-names></name><name><surname>Roberts</surname><given-names>D.</given-names></name><name><surname>Hölscher</surname><given-names>C.</given-names></name><name><surname>Elliott</surname><given-names>C. T.</given-names></name><name><surname>Green</surname><given-names>B. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of alzheimer's disease</article-title>. <source>Anal. Chem.</source>
<volume>85</volume>, <fpage>1803</fpage>–<lpage>1811</lpage>. <pub-id pub-id-type="doi">10.1021/ac303163f</pub-id><?supplied-pmid 23252551?><pub-id pub-id-type="pmid">23252551</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Graber</surname><given-names>A.</given-names></name><name><surname>McBurney</surname><given-names>R.</given-names></name><name><surname>Balasubramanian</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms</article-title>. <source>BMC Bioinformatics</source>
<volume>11</volume>:<fpage>447</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-11-447</pub-id><?supplied-pmid 20815881?><pub-id pub-id-type="pmid">20815881</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyon</surname><given-names>I.</given-names></name><name><surname>Elisseeff</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>An introduction to variable and feature selection</article-title>. <source>J. Mach. Learn. Res.</source>
<volume>3</volume>, <fpage>1157</fpage>–<lpage>1182</lpage>.</mixed-citation>
    </ref>
    <ref id="B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyon</surname><given-names>I.</given-names></name><name><surname>Weston</surname><given-names>J.</given-names></name><name><surname>Barnhill</surname><given-names>S.</given-names></name><name><surname>Vapnik</surname><given-names>V.</given-names></name></person-group> (<year>2002</year>). <article-title>Gene selection for cancer classification using support vector machines</article-title>. <source>Mach. Learn.</source>
<volume>46</volume>, <fpage>389</fpage>–<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1023/A:1012487302797</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Hastie</surname><given-names>T.</given-names></name><name><surname>Tibshirani</surname><given-names>R.</given-names></name><name><surname>Narasimhan</surname><given-names>B.</given-names></name><name><surname>Chu</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <source>pamr: Pam: Prediction Analysis for Microarrays</source>. R package version 1.55.</mixed-citation>
    </ref>
    <ref id="B31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haury</surname><given-names>A.-C.</given-names></name><name><surname>Gestraud</surname><given-names>P.</given-names></name><name><surname>Vert</surname><given-names>J.-P.</given-names></name></person-group> (<year>2011</year>). <article-title>The influence of feature selection methods on accuracy, stability and interpretability of molecular signatures</article-title>. <source>PLoS ONE</source>
<volume>6</volume>:<fpage>e28210</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0028210</pub-id><?supplied-pmid 22205940?><pub-id pub-id-type="pmid">22205940</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>E.</given-names></name><name><surname>Wilson</surname><given-names>I. D.</given-names></name><name><surname>Nicholson</surname><given-names>J. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Metabolic phenotyping in health and disease</article-title>. <source>Cell</source>
<volume>134</volume>, <fpage>714</fpage>–<lpage>717</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.08.026</pub-id><?supplied-pmid 18775301?><pub-id pub-id-type="pmid">18775301</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keating</surname><given-names>P.</given-names></name><name><surname>Cambrosio</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Too many numbers: microarrays in clinical cancer research</article-title>. <source>Stud. Hist. Philos. Biol. Biomed. Sci.</source>
<volume>43</volume>, <fpage>37</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.shpsc.2011.10.004</pub-id><?supplied-pmid 22326071?><pub-id pub-id-type="pmid">22326071</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohavi</surname><given-names>R.</given-names></name><name><surname>John</surname><given-names>G. H.</given-names></name></person-group> (<year>1997</year>). <article-title>Wrappers for feature subset selection</article-title>. <source>Artif. Intell.</source>
<volume>97</volume>, <fpage>273</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/S0004-3702(97)00043-X</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhl</surname><given-names>C.</given-names></name><name><surname>Tautenhahn</surname><given-names>R.</given-names></name><name><surname>Böttcher</surname><given-names>C.</given-names></name><name><surname>Larson</surname><given-names>T. R.</given-names></name><name><surname>Neumann</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Camera: an integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets</article-title>. <source>Anal. Chem.</source>
<volume>84</volume>, <fpage>283</fpage>–<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1021/ac202450g</pub-id><?supplied-pmid 22111785?><pub-id pub-id-type="pmid">22111785</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>M.</given-names></name><name><surname>Johnson</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>An introduction to feature selection</article-title>, in <source>Applied Predictive Modeling</source> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>487</fpage>–<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4614-6849-3_19</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liaw</surname><given-names>A.</given-names></name><name><surname>Wiener</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Classification and regression by randomforest</article-title>. <source>R News</source>
<volume>2</volume>, <fpage>18</fpage>–<lpage>22</lpage>. <?supplied-pmid 23795347?><pub-id pub-id-type="pmid">23795347</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lustgarten</surname><given-names>J. L.</given-names></name><name><surname>Gopalakrishnan</surname><given-names>V.</given-names></name><name><surname>Visweswaran</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Measuring stability of feature selection in biomedical datasets</article-title>. <source>Proc. AMIA Ann. Symp.</source>
<volume>2009</volume>, <fpage>406</fpage>–<lpage>410</lpage>. <?supplied-pmid 20351889?><pub-id pub-id-type="pmid">20351889</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname><given-names>R.</given-names></name><name><surname>Lundstedt</surname><given-names>T.</given-names></name><name><surname>Trygg</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Chemometrics in metabolomics-a review in human disease diagnosis</article-title>. <source>Anal. Chim. Acta</source>
<volume>659</volume>, <fpage>23</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.aca.2009.11.042</pub-id><?supplied-pmid 20103103?><pub-id pub-id-type="pmid">20103103</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mapstone</surname><given-names>M.</given-names></name><name><surname>Cheema</surname><given-names>A. K.</given-names></name><name><surname>Fiandaca</surname><given-names>M. S.</given-names></name><name><surname>Zhong</surname><given-names>X.</given-names></name><name><surname>Mhyre</surname><given-names>T. R.</given-names></name><name><surname>MacArthur</surname><given-names>L. H.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Plasma phospholipids identify antecedent memory impairment in older adults</article-title>. <source>Nat. Med.</source><volume>20</volume>, <fpage>415</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3466</pub-id><?supplied-pmid 24608097?><pub-id pub-id-type="pmid">24608097</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>T.</given-names></name><name><surname>Kuriyama</surname><given-names>K.</given-names></name><name><surname>Miyazaki</surname><given-names>Y.</given-names></name><name><surname>Yoshida</surname><given-names>S.</given-names></name><name><surname>Tomonaga</surname><given-names>M.</given-names></name><name><surname>Emi</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype</article-title>. <source>Leukemia</source><volume>17</volume>, <fpage>1538</fpage>–<lpage>1543</lpage>. <pub-id pub-id-type="doi">10.1038/sj.leu.2403010</pub-id><?supplied-pmid 12886240?><pub-id pub-id-type="pmid">12886240</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehmood</surname><given-names>T.</given-names></name><name><surname>Liland</surname><given-names>K. H.</given-names></name><name><surname>Snipen</surname><given-names>L.</given-names></name><name><surname>Saebo</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>A review of variable selection methods in partial least squares regression</article-title>. <source>Chemometr. Intell. Lab. Syst.</source>
<volume>118</volume>, <fpage>62</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.chemolab.2012.07.010</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>D.</given-names></name><name><surname>Dimitriadou</surname><given-names>E.</given-names></name><name><surname>Hornik</surname><given-names>K.</given-names></name><name><surname>Weingessel</surname><given-names>A.</given-names></name><name><surname>Leisch</surname><given-names>F.</given-names></name></person-group> (<year>2014</year>). <source>e1071: Misc Functions of the Department of Statistics (e1071), TU Wien</source>. R package version 1.6-4.</mixed-citation>
    </ref>
    <ref id="B44">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>J. K.</given-names></name></person-group> (<year>2006</year>). <article-title>Global systems biology, personalized medicine and molecular epidemiology</article-title>. <source>Mol. Syst. Biol.</source>
<volume>2</volume>:<fpage>52</fpage>. <pub-id pub-id-type="doi">10.1038/msb4100095</pub-id><?supplied-pmid 17016518?><pub-id pub-id-type="pmid">17016518</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posada-Ayala</surname><given-names>M.</given-names></name><name><surname>Zubiri</surname><given-names>I.</given-names></name><name><surname>Martin-Lorenzo</surname><given-names>M.</given-names></name><name><surname>Sanz-Maroto</surname><given-names>A.</given-names></name><name><surname>Molero</surname><given-names>D.</given-names></name><name><surname>Gonzalez-Calero</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease</article-title>. <source>Kidney Int.</source><volume>85</volume>, <fpage>103</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1038/ki.2013.328</pub-id><?supplied-pmid 24048377?><pub-id pub-id-type="pmid">24048377</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prawitt</surname><given-names>J.</given-names></name><name><surname>Caron</surname><given-names>S.</given-names></name><name><surname>Staels</surname><given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>Bile acid metabolism and the pathogenesis of type 2 diabetes</article-title>. <source>Curr. Diabetes Rep.</source>
<volume>11</volume>, <fpage>160</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1007/s11892-011-0187-x</pub-id><?supplied-pmid 21431855?><pub-id pub-id-type="pmid">21431855</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rifai</surname><given-names>N.</given-names></name><name><surname>Gillette</surname><given-names>M. A.</given-names></name><name><surname>Carr</surname><given-names>S. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Protein biomarker discovery and validation: the long and uncertain path to clinical utility</article-title>. <source>Nat. Biotechnol.</source>
<volume>24</volume>, <fpage>971</fpage>–<lpage>983</lpage>. <pub-id pub-id-type="doi">10.1038/nbt1235</pub-id><?supplied-pmid 16900146?><pub-id pub-id-type="pmid">16900146</pub-id></mixed-citation>
    </ref>
    <ref id="B48">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>L. D.</given-names></name><name><surname>Koulman</surname><given-names>A.</given-names></name><name><surname>Griffin</surname><given-names>J. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome</article-title>. <source>Lancet Diabetes Endocrinol.</source>
<volume>2</volume>, <fpage>65</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-8587(13)70143-8</pub-id><?supplied-pmid 24622670?><pub-id pub-id-type="pmid">24622670</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robotti</surname><given-names>E.</given-names></name><name><surname>Manfredi</surname><given-names>M.</given-names></name><name><surname>Marengo</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Biomarkers discovery through multivariate statistical methods: a review of recently developed methods and applications in proteomics</article-title>. <source>J. Proteom. Bioinform.</source>
<volume>S3</volume>:<fpage>003</fpage>
<pub-id pub-id-type="doi">10.4172/jpb.S3-003</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roux</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Heilier</surname><given-names>J.-F.</given-names></name><name><surname>Olivier</surname><given-names>M.-F.</given-names></name><name><surname>Ezan</surname><given-names>E.</given-names></name><name><surname>Tabet</surname><given-names>J.-C.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Annotation of the human adult urinary metabolome and metabolite identification using ultra high performance liquid chromatography coupled to a linear quadrupole ion trap-orbitrap mass spectrometer</article-title>. <source>Anal. Chem.</source><volume>84</volume>, <fpage>6429</fpage>–<lpage>6437</lpage>. <pub-id pub-id-type="doi">10.1021/ac300829f</pub-id><?supplied-pmid 22770225?><pub-id pub-id-type="pmid">22770225</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowe</surname><given-names>I.</given-names></name><name><surname>Chiaravalli</surname><given-names>M.</given-names></name><name><surname>Mannella</surname><given-names>V.</given-names></name><name><surname>Ulisse</surname><given-names>V.</given-names></name><name><surname>Quilici</surname><given-names>G.</given-names></name><name><surname>Pema</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy</article-title>. <source>Nat. Med.</source><volume>19</volume>, <fpage>488</fpage>–<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3092</pub-id><?supplied-pmid 23524344?><pub-id pub-id-type="pmid">23524344</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeys</surname><given-names>Y.</given-names></name><name><surname>Inza</surname><given-names>I.</given-names></name><name><surname>Larrañaga</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>A review of feature selection techniques in bioinformatics</article-title>. <source>Bioinformatics</source>
<volume>23</volume>, <fpage>2507</fpage>–<lpage>2517</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btm344</pub-id><?supplied-pmid 17720704?><pub-id pub-id-type="pmid">17720704</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>I.</given-names></name><name><surname>Lin</surname><given-names>W.</given-names></name><name><surname>Liakata</surname><given-names>M.</given-names></name><name><surname>Wood</surname><given-names>J.</given-names></name><name><surname>Vermeer</surname><given-names>C.</given-names></name><name><surname>Allaway</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Merits of random forests emerge in evaluation of chemometric classifiers by external validation</article-title>. <source>Anal. Chim. Acta</source><volume>801</volume>, <fpage>22</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.aca.2013.09.027</pub-id><?supplied-pmid 24139571?><pub-id pub-id-type="pmid">24139571</pub-id></mixed-citation>
    </ref>
    <ref id="B54">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>C. A.</given-names></name><name><surname>Want</surname><given-names>E. J.</given-names></name><name><surname>O'Maille</surname><given-names>G.</given-names></name><name><surname>Abagyan</surname><given-names>R.</given-names></name><name><surname>Siuzdak</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification</article-title>. <source>Anal. Chem.</source>
<volume>78</volume>, <fpage>779</fpage>–<lpage>787</lpage>. <pub-id pub-id-type="doi">10.1021/ac051437y</pub-id><?supplied-pmid 16448051?><pub-id pub-id-type="pmid">16448051</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumner</surname><given-names>L. W.</given-names></name><name><surname>Amberg</surname><given-names>A.</given-names></name><name><surname>Barrett</surname><given-names>D.</given-names></name><name><surname>Beale</surname><given-names>M. H.</given-names></name><name><surname>Beger</surname><given-names>R.</given-names></name><name><surname>Daykin</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Proposed minimum reporting standards for chemical analysis</article-title>. <source>Metabolomics</source><volume>3</volume>, <fpage>211</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1007/s11306-007-0082-2</pub-id><?supplied-pmid 24039616?><pub-id pub-id-type="pmid">24039616</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szymanska</surname><given-names>E.</given-names></name><name><surname>Saccenti</surname><given-names>E.</given-names></name><name><surname>Smilde</surname><given-names>A.</given-names></name><name><surname>Westerhuis</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Double-check: validation of diagnostic statistics for pls-da models in metabolomics studies</article-title>. <source>Metabolomics</source>
<volume>8</volume>, <fpage>3</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1007/s11306-011-0330-3</pub-id><?supplied-pmid 22593721?><pub-id pub-id-type="pmid">22593721</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarca</surname><given-names>A. L.</given-names></name><name><surname>Lauria</surname><given-names>M.</given-names></name><name><surname>Unger</surname><given-names>M.</given-names></name><name><surname>Bilal</surname><given-names>E.</given-names></name><name><surname>Boue</surname><given-names>S.</given-names></name><name><surname>Kumar Dey</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Strengths and limitations of microarray-based phenotype prediction: lessons learned from the improver diagnostic signature challenge</article-title>. <source>Bioinformatics</source><volume>29</volume>, <fpage>2892</fpage>–<lpage>2899</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt492</pub-id><?supplied-pmid 23966112?><pub-id pub-id-type="pmid">23966112</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>D. R.</given-names></name><name><surname>Alaghband-Zadeh</surname><given-names>J.</given-names></name><name><surname>Cross</surname><given-names>G. F.</given-names></name><name><surname>Omar</surname><given-names>S.</given-names></name><name><surname>le Roux</surname><given-names>C. W.</given-names></name><name><surname>Vincent</surname><given-names>R. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m<sup>2</sup></article-title>. <source>PLoS ONE</source>
<volume>9</volume>:<fpage>e93540</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0093540</pub-id><pub-id pub-id-type="pmid">24736330</pub-id></mixed-citation>
    </ref>
    <ref id="B59">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thevenot</surname><given-names>E. A.</given-names></name><name><surname>Roux</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Ezan</surname><given-names>E.</given-names></name><name><surname>Junot</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and opls statistical analyses</article-title>. <source>J. Prot. Res.</source>
<volume>14</volume>, <fpage>3322</fpage>–<lpage>3335</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.5b00354</pub-id><?supplied-pmid 26088811?><pub-id pub-id-type="pmid">26088811</pub-id></mixed-citation>
    </ref>
    <ref id="B60">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tibshirani</surname><given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>Regression shrinkage and selection via the lasso</article-title>. <source>J. R. Stat. Soc. Ser. B (Methodol.)</source>
<volume>58</volume>, <fpage>267</fpage>–<lpage>288</lpage>.</mixed-citation>
    </ref>
    <ref id="B61">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tibshirani</surname><given-names>R.</given-names></name><name><surname>Hastie</surname><given-names>T.</given-names></name><name><surname>Narasimhan</surname><given-names>B.</given-names></name><name><surname>Chu</surname><given-names>G.</given-names></name></person-group> (<year>2002</year>). <article-title>Diagnosis of multiple cancer types by shrunken centroids of gene expression</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>99</volume>, <fpage>6567</fpage>–<lpage>6572</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.082099299</pub-id><?supplied-pmid 12011421?><pub-id pub-id-type="pmid">12011421</pub-id></mixed-citation>
    </ref>
    <ref id="B62">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trygg</surname><given-names>J.</given-names></name><name><surname>Holmes</surname><given-names>E.</given-names></name><name><surname>Lundstedt</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Chemometrics in metabonomics</article-title>. <source>J. Prot. Res.</source>
<volume>6</volume>, <fpage>469</fpage>–<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1021/pr060594q</pub-id><?supplied-pmid 17269704?><pub-id pub-id-type="pmid">17269704</pub-id></mixed-citation>
    </ref>
    <ref id="B63">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van 't Veer</surname><given-names>L. J.</given-names></name><name><surname>Bernards</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Enabling personalized cancer medicine through analysis of gene-expression patterns</article-title>. <source>Nature</source>
<volume>452</volume>, <fpage>564</fpage>–<lpage>570</lpage>. <?supplied-pmid 18385730?><pub-id pub-id-type="pmid">18385730</pub-id></mixed-citation>
    </ref>
    <ref id="B64">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T. J.</given-names></name><name><surname>Larson</surname><given-names>M. G.</given-names></name><name><surname>Vasan</surname><given-names>R. S.</given-names></name><name><surname>Cheng</surname><given-names>S.</given-names></name><name><surname>Rhee</surname><given-names>E. P.</given-names></name><name><surname>McCabe</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Metabolite profiles and the risk of developing diabetes</article-title>. <source>Nat. Med.</source><volume>17</volume>, <fpage>448</fpage>–<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2307</pub-id><?supplied-pmid 21423183?><pub-id pub-id-type="pmid">21423183</pub-id></mixed-citation>
    </ref>
    <ref id="B65">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wehrens</surname><given-names>R.</given-names></name><name><surname>Franceschi</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Meta-statistics for variable selection: the R package BioMark</article-title>. <source>J. Stat. Softw.</source>
<volume>51</volume>, <fpage>1</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.18637/jss.v051.i10</pub-id><pub-id pub-id-type="pmid">23504300</pub-id></mixed-citation>
    </ref>
    <ref id="B66">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wold</surname><given-names>S.</given-names></name><name><surname>Sjöström</surname><given-names>M.</given-names></name><name><surname>Eriksson</surname><given-names>L.</given-names></name></person-group> (<year>2001</year>). <article-title>PLS-regression: a basic tool of chemometrics</article-title>. <source>Chemometr. Intell. Laboratory Syst.</source>
<volume>58</volume>, <fpage>109</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/S0169-7439(01)00155-1</pub-id></mixed-citation>
    </ref>
    <ref id="B67">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>A.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Yan</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group> (<year>2015</year>). <article-title>Metabolomics for biomarker discovery: moving to the clinic</article-title>. <source>BioMed Res. Int.</source>
<volume>2015</volume>:<fpage>354671</fpage>. <pub-id pub-id-type="doi">10.1155/2015/354671</pub-id><?supplied-pmid 26090402?><pub-id pub-id-type="pmid">26090402</pub-id></mixed-citation>
    </ref>
    <ref id="B68">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.-Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Metabolomics in chronic kidney disease</article-title>. <source>Clin. Chimica Acta</source>
<volume>422</volume>, <fpage>59</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2013.03.033</pub-id><?supplied-pmid 23570820?><pub-id pub-id-type="pmid">23570820</pub-id></mixed-citation>
    </ref>
    <ref id="B69">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>H.</given-names></name><name><surname>Hastie</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>Regularization and variable selection via the elastic net</article-title>. <source>J. R. Stat.</source>
<volume>67</volume>, <fpage>301</fpage>–<lpage>320</lpage>. <pub-id pub-id-type="doi">10.1111/j.1467-9868.2005.00503.x</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
